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ABSTRACT 
Meagan F. Vaughn: Tick-borne Diseases in North Carolina: Seroepidemiology of Spotted 
Fever Group Rickettsiae and Prevention of Tick Bites Among Outdoor Workers  
(Under the direction of Steven Meshnick) 
 
Tick-borne diseases are the most common vector-borne diseases in the US.  North 
Carolina suffers from some of the highest rates of Rocky Mountain spotted fever (RMSF), 
which can cause severe illness and death. 
The first aim of this dissertation explored whether spotted fever group rickettsiae (SFGR) 
other than Rickettsia rickettsii are responsible for spotted fever rickettsioses in North 
Carolina.  A retrospective seroepidemiologic study was conducted in which the reactivity of 
paired sera from North Carolina patients who had been tested for RMSF we evaluated 
against a panel of SFGR, including R. rickettsii, R. amblyommii, and R. parkeri.  Of the 106 
eligible pairs tested, 21 patients seroconverted to one or more antigens.  Cross-reactivity 
was observed in ten patients and seroconversions to single antigens occurred in 11 
patients, including one against R. rickettsii, four against R. parkeri, and six against R. 
amblyommii.  These findings suggest that species other than R. rickettsii are associated with 
illness among North Carolina residents. 
The second aim of this dissertation focused on tick bite prevention among North 
Carolina outdoor workers.  A double-blind randomized controlled trial was conducted to 
evaluate the protective effectiveness of long-lasting permethrin impregnated (LLPI) uniforms
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among workers from North Carolina State Divisions of Forestry, Parks and Recreation, and 
Wildlife.  159 subjects were randomized; uniforms of participants in the treatment group 
were factory-impregnated with long-lasting permethrin while control group uniforms received 
a sham treatment.  Participants continued standard recommended tick-bite prevention 
activities and provided weekly tick bite logs during two tick seasons. 130 subjects reported 
1,045 work-related tick bites over 5,251 person-weeks of follow-up.  The effectiveness of 
LLPI uniforms for the prevention of work-related tick bites was 0.82 (95% Confidence 
Interval (CI): 0.66, 0.91) for the first year of follow-up and 0.34 (95% CI: -0.67, 0.74) for the 
second year of follow-up.  These results indicate that LLPI uniforms are highly effective for 
at least one year against tick bites in the context of existing tick bite prevention measure 
usage by outdoor workers.   
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Chapter 1 
SPECIFIC AIMS 
 
As the incidence of tick-borne diseases continues to rise in the US, particularly for cases 
of Rocky Mountain spotted fever (RMSF) in the southern and southeastern US, questions as 
to the reasons for these dramatic increases continue to puzzle experts.  The epidemiology 
of RMSF appears to be changing, and there is mounting evidence that infections with other 
spotted fever group rickettsiae (SFGR) are at least partly responsible for the increases in 
incidence and the decreases in case-fatality rates of reported cases of RMSF.  Among 
outdoor workers, it has been well documented that the risk of tick-borne diseases is greater 
than that of the general population.  These diseases, which can cause severe illness and 
death, are of particular concern for workers who have frequent exposure to tick-infested 
habitats, such as foresters, park rangers, land surveyors and other outdoor workers.  Many 
North Carolina state employees with outdoor occupations report multiple tick bites each 
year, which indicates that existing tick preventive strategies may be ineffective.  A new 
technology which allows clothing to be impregnated with long-lasting permethrin, a chemical 
known for its insecticidal properties, may be a simple method to reduce tick bites and tick-
borne disease.   
The specific aims for this dissertation are to: 
1. Evaluate the serologic reactivity of samples collected from North Carolina 
patients tested for RMSF to Rickettsia rickettsii, R. amblyommii, and R. parkeri 
antigens.
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2. Evaluate the effectiveness of wearing permethrin impregnated uniforms for the 
prevention of tick bites among North Carolina outdoor workers. 
Aim 1 was accomplished through a retrospective analysis of North Carolina reportable 
disease surveillance data and stored serum samples at the North Carolina State Laboratory 
of Public Health (NCSLPH).  Paired sera (acute and convalescent) submitted to the 
NCSLPH from patients suspected to have a tick-borne illness from 2008 to 2010 were 
tested against a panel of SFGR antigens using an indirect immunofluorescence assay (IFA).  
Criteria for inclusion in the study included patients for which there were paired sera available 
that had been submitted to the NCSLPH for testing against R. rickettsii and at least one of 
the sera had a titer ≥1:64.  Data from the surveillance report were reviewed and information 
regarding clinical signs and symptoms, treatment, and recovery were extracted.  Disease 
severity and patient outcomes were compared for patients who had serologically confirmed 
RMSF (four-fold or greater rise in titer to R. rickettsii between paired specimens) and 
patients who had fourfold or greater rises in titers to other SFGR (R. amblyommii or R. 
parkeri).     
Aim 2 was accomplished through a double-blind randomized intervention including 
employees from the North Carolina Division of Forest Resources, the North Carolina 
Division of Parks and Recreation, North Carolina County Parks and Recreation, and North 
Carolina Wildlife Resources Commission.  Participants who were enrolled in the study were 
randomized into the placebo or treatment groups and were asked to submit all of their work 
uniforms to Insect Shield, LLC (Greensboro, NC).  The uniforms of participants in the 
treatment group were treated with permethrin using a proprietary process developed by 
Insect Shield, which allows clothing to retain insecticidal activity for 70 machine washes.  
Uniforms from members of the control group did not receive permethrin treatment, and were 
washed and refolded.  Questionnaires which collected general information on tick exposure 
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and tick bite prevention practices were administered to participants at enrollment and after 
each tick season.  All participants were asked to record any tick bites during the study 
period on weekly tick bite logs.  The incidence rate ratios (and 95% confidence intervals) for 
tick bites comparing the treatment and control groups, stratified by year of follow-up, were 
estimated using a generalized estimating equations (GEE) approach for Poisson regression. 
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Chapter 2 
INTRODUCTION AND LITERATURE REVIEW 
 
The most common vector-borne diseases in the US are those carried by ticks.  Over the 
past two decades the incidence of tick-borne diseases such as Lyme disease, Rocky 
Mountain spotted fever (RMSF), human monocytic ehrlichiosis (HME), and human 
granulocytic anaplasmosis (HGA) have been increasing at an remarkable rate [1-5]. 
Recently the CDC estimated that there are approximately 300,000 cases of Lyme disease 
diagnosed in the US each year, more than ten times the number of cases that are actually 
reported [6]. Under ascertainment is also likely for other tick-borne diseases such as RMSF. 
The incidence of RMSF, the most commonly reported fatal tick-borne disease in the US, has 
also been rising in recent years from 2.5 cases per million in 2001 to 9.5 cases per million in 
2011 [7].  These tick-borne diseases, which can cause serious illness or death if not treated 
early, pose a substantial public health threat in highly endemic areas.  One such endemic 
area, commonly referred to as the “tick belt”, which stretches from Oklahoma to North 
Carolina, is home to at least four species of ticks known to carry human pathogens [8, 9].  
This region suffers from some of the highest rates of tick-borne rickettsial diseases such 
RMSF and HME [2] (Figure 1).   
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Figure 1. Average reported annual incidence of Rocky Mountain spotted fever, 2010 [10]. 
In addition to rising incidence rates, the public health threat posed by tick-borne 
diseases has been compounded by the emergence of several “new” tick-borne diseases.  
The lone star tick (Amblyomma americanum) is one of the most abundant species of ticks in 
the southeastern US and is known for it’s aggressive feeding on large mammals, including 
deer and humans [11].  Formerly considered a “nuisance” species, the lone star tick is now 
known to be an important vector.  Since the 1980s, increasing reports of an illness with 
clinical manifestations similar to Lyme disease has been described among people bitten by 
lone star ticks [12-14].  The etiology of this disease, named southern tick-associated rash 
illness or STARI, is still unknown. There is also evidence that other species of spotted fever 
group rickettsiae such as Rickettsia amblyommii and Rickettsia parkeri, previously thought 
to be non-pathogenic in humans, are capable of causing disease [15-19].   
A. Seroepidemiology of spotted fever group rickettsiae 
Spotted fever group rickettsiae (SFGR) are obligate intracellular gram negative bacteria 
that are transmitted to mammals through the bite of an infected tick, flea, or mite.  Up until 
the 1980s, the only SFGR known to cause disease in humans in the United States was 
Rickettsia rickettsii, the agent of RMSF [20].  In the US, the primary tick vectors for R. 
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rickettsii are the American dog tick (Dermacentor variabilis), the Rocky Mountain wood tick 
(Dermacentor andersoni), and more recently the brown dog tick (Rhipicephaulus 
sanguineus).  Contrary to its name, the highest rates of RMSF are in central and eastern 
parts of the US, with North Carolina, Tennessee, Arkansas, and Oklahoma representing the 
states with the highest incidence of reported cases [2, 20].  D. variabilis is the established 
vector for R. rickettsii in this region, although R. rickettsii has been detected in less than 1% 
of these ticks in recent tick surveys [21-25]. 
1. Clinical presentation of RMSF 
The typical constellation of symptoms for a case of RMSF includes fever, headache, and 
myalgia, followed by the development of a maculopapular rash which may progress to a 
petechial rash.  Other symptoms reported include malaise, abdominal pain, nausea, 
vomiting, anorexia, or altered mental status.  The onset of symptoms usually occurs within 
14 days of the tick bite, although many patients do not recall being bitten. The rash is 
ultimately observed in approximately 80% of cases, although less than 50% have it at the 
time of first presentation to a medical provider [2].  The majority of cases reported have an 
onset of illness between April and September.  RMSF is often a severe illness, and historical 
estimates of case-fatality rates in the early 20th century were well above 20%, while more 
recent estimates range between 2% and 6% [26].  Even with appropriate antibiotic treatment 
many patients are hospitalized; of the cases reported to the CDC between 1997 and 2002, 
35% were hospitalized with a 1.4% case-fatality rate [3].   
2. Clinical and laboratory diagnosis of RMSF 
Diagnosis of RMSF can be difficult due to the nonspecific symptoms in the early stages 
of the illness.  If a tick-borne rickettsial disease is suspected, doxycycline is the antibiotic of 
choice and treatment should not be delayed for a laboratory confirmation since sensitive 
diagnostic tests are not available in the early phase of disease.  Several tests can be used 
to confirm infection with R. rickettsii, including serologic tests on acute and convalescent 
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sera, detection of rickettsial DNA in blood or skin biopsy samples, immunohistochemical 
staining of skin biopsy tissue, and culture.  Serologic testing is the primary method of 
laboratory diagnosis for RMSF; the most common methods used being the indirect 
immunofluorescent antibody assay (IFA) and enzyme-linked immunosorbent assay (ELISA).  
The IFA is considered the gold standard since it is quantitative (unlike the ELISA) and has a 
high sensitivity and specificity (85-97% sensitivity and 100% specificity for a single 
convalescent sample) [27].  A four-fold or greater change in IgG titer (seroconversion) 
against R. rickettsii antigen between appropriately timed acute and convalescent serum 
samples is sufficient for laboratory confirmation.  Elevated IgG and IgM titers are usually not 
observed until the second or third week of illness, and detectable antibodies are often not 
found in acute samples collected in the first seven days of illness, therefore a second 
sample collected 2-4 weeks after onset of illness is required to demonstrate seroconversion.  
For surveillance purposes, a single elevated IgG or IgM titer against R. rickettsii antigen can 
be used as supportive laboratory evidence for infection, but is not sufficient for confirmation 
as it may only represent the presence of antibodies from a prior infection.  It is unknown how 
long antibodies to SFGR persist, but one study demonstrated that patients infected with R. 
rickettsii still had detectable antibodies after 12 months [28].   
3. Surveillance case definitions 
In 2010 the case classification for RMSF was changed by the Council of State and 
Territorial Epidemiologists to reflect the likelihood that some cases being reported as RMSF 
under the prior classification may be due to other SFGR, and is now designated as “Spotted 
Fever Group Rickettsiosis (including Rocky Mountain spotted fever)”.  The current case 
definitions used for surveillance include [29]: 
 Suspected: A case with laboratory evidence of past or present infection but no 
clinical information available (e.g. a laboratory report). 
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 Probable: A clinically compatible case (meets clinical evidence criteria) that has 
supportive laboratory results. 
 Confirmed: A clinically compatible case (meets clinical evidence criteria) that is 
laboratory confirmed. 
A clinically compatible case must have reported fever and one or more of the following 
symptoms or clinical findings: compatible rash, eschar, headache, myalgia, anemia, 
thrombocytopenia, or any hepatic transaminase elevation [29].  Clinical findings of anemia, 
thrombocytopenia, or hepatic transaminase elevation are defined as exceeding the 
laboratory defined upper or lower bounds for normal values.  Laboratory confirmation can be 
achieved by any one of the following methods:  
 Serological evidence of a fourfold change in immunoglobulin G (IgG)-specific 
antibody titer reactive with Rickettsia rickettsii or other spotted fever group antigen by 
indirect immunofluorescence assay (IFA) between paired serum specimens (one 
taken in the first week of illness and a second 2-4 weeks later). 
 Detection of R. rickettsii or other spotted fever group DNA in a clinical specimen via 
amplification of a specific target by PCR assay. 
 Demonstration of spotted fever group antigen in a biopsy or autopsy specimen by 
immunohistochemistry (IHC). 
 Isolation of R. rickettsii or other spotted fever group rickettsia from a clinical 
specimen in cell culture. 
For supportive laboratory results, the patient must have serologic evidence of elevated 
IgG or IgM antibody reactive with R. rickettsii or other spotted fever group antigen by IFA, 
enzyme-linked immunosorbent assay (ELISA), dot-ELISA, or latex agglutination [29]. 
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4. Trends in incidence and mortality 
Since national surveillance for RMSF began in 1920, incidence in the US has gone 
through large fluctuations (Figure 2).  Experts have suggested several possible reasons for 
some of the major periods of change, such as changes in agencies responsible for 
collecting surveillance data, the death of prominent RMSF researcher Ralph Parker in 1949, 
changes in case definitions, the availability of improved diagnostic tests, improved education 
and disease reporting, and recognition of RMSF in the eastern US [26, 30].  Other factors 
that may have played a role in the changes in incidence observed in the US include 
variation in the virulence of R. rickettsii, changes in use of pesticides (DDT), competition with 
other species of Rickettsia in tick vectors, and increased human contact with tick vectors 
due to increases in population, recreation, and suburbanization [26].   
A general decreasing trend was observed through the 1980s and 1990s, reaching its 
lowest point at 1.4 cases per million in 1998.  Since 1998 there has been unprecedented 
and dramatic rise in the incidence of RMSF, with more than a 5-fold increase in the span of 
a decade to an all-time high of 8.4 cases per million in 2008 [10].  This time period also 
marked a rapid decline in the reported case fatality rate for RMSF, which also reached an 
all-time low of 0.5% in 2008.  Since treatment options and clinical management of cases of 
RMSF has not changed for many years, this decrease in mortality is difficult to explain.  
Several events related to RMSF surveillance occurred in the past decade that may account 
for some of the increase in incidence, including the introduction and promotion of a new 
case reporting form in 2001, changes in the case definition in 2004, publication of national 
guidelines for diagnosis, treatment, and management of tick-borne rickettsial diseases in 
2006, and increases in the amount of funding for public health preparedness available to 
state health departments [30].   
A decreasing trend in the percent of RMSF cases that are confirmed and an increase in 
the number of probable cases accompany the increases in incidence and decreases in 
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case-fatality from 1998 to 2008.  The case-fatality rate among confirmed cases was 10 times 
that of probable cases between 2000 and 2007, and suggests that probable cases may 
represent previous exposure to a SFGR rather than an incident infection [30].  This theory is 
supported by several studies showing that seroprevalence to SFGR is between 6% and 
12% based on serosurveys of adults and children in the US [31, 32].  In addition, a recent 
geospatial analysis of the relative severity of RMSF cases in the US by county found two 
clusters of less severe disease in central and south-central North Carolina [33].  This finding 
may indicate that there is better detection, diagnosis and treatment of RMSF in North 
Carolina, or that milder strains or less pathogenic species of rickettsiae are circulating in this 
region.  Since subclinical infection or mild infections with R. rickettsii are considered by 
experts to be rare or even non-existent [18], exposure to non-pathogenic or less pathogenic 
species of SFGR is likely to account for the relatively high seroprevalence to R. rickettsii and 
may also account for some of  the increased incidence and decreased case-fatality 
observed in recent years.   
 
Figure 2.  Incidence and case-fatality rates for Rocky Mountain spotted fever, 1920-2008. 
Source: http://www.cdc.gov/rmsf/stats/ 
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5. Risk factors for RMSF 
RMSF occurs more frequently in males, of the cases reported between 2000 and 2007, 
57% of cases were male [30].  While whites make up the majority of the reported cases 
(87% of cases reported from 2000-2007), American Indians suffer from disproportionately 
high rates of RMSF (16.8 cases per million compared to 4.4 cases per million for whites) 
[30].  Historically, the highest incidence of RMSF was seen in children under age 10 [2, 4], 
but in recent years the incidence of RMSF in older adults has surpassed that of children 
(Figure 3).   
 
Figure 3.  Age-specific incidence of Rocky Mountain spotted fever cases reported between 
2000 and 2008.  Source: http://www.cdc.gov/rmsf/stats/ 
 
6. Emergent and possible emerging SFGR in the US 
Worldwide there are a large number of SFGR that are known to cause disease in 
humans, including Rickettsia africae (African Tick Bite Fever), Rickettsia conorii 
(Mediterranean Spotted Fever), Rickettsia sibirica (Siberian Tick Typhus), and many others. 
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In addition to R. rickettsii, several other species of SFGR have been isolated from ticks in 
the US, but most have not been implicated in causing human illness.   
a. Rickettsia parkeri 
Rickettsia parkeri was first isolated in 1939 from Gulf Coast ticks (Amblyomma 
maculatum) and was considered to be nonpathogenic for many years until 2002, when it 
was isolated from a patient in Virginia [19, 34]. Additional cases from Virginia, Mississippi, 
Kentucky, South Carolina, and Maryland were described in subsequent years [24, 35, 36].  
R. parkeri appears to cause a milder illness than classic RMSF, and eschars at the site of 
inoculation are common (which are rarely described in cases of RMSF).  A review of case 
reports submitted to the CDC between 1998 and 2007 for which an eschar or vesicular rash 
was reported  found 12 confirmed and probable cases of R. parkeri rickettsiosis based on 
laboratory results using culture, PCR, IHC, or group-specific IFA against several species of 
SFGR [36].  R. parkeri rickettsiosis cases were less severe overall compared to RMSF 
cases; with lower percentages of hospitalization, death, nausea/vomiting, diarrhea, and 
coma/delirium/seizures.  Eschars were present in nearly all cases.  The range for A. 
maculatum includes the coastal areas of the southeastern US and extends further inland in 
some states such as Kansas and Oklahoma [37]. Recent entomologic surveys in this region 
have found R. parkeri in 11-43% of Gulf Coast ticks [37-41].   
b. Rickettsia amblyommii 
Rickettsia amblyommii was first isolated from lone star ticks (Amblyomma americanum) 
in Tennessee in 1974 [42].  The range of A. americanum covers much of the eastern US, 
stretching as far north as New England and west to Texas and Oklahoma [2].  R. 
amblyommii is found in a high proportion of lone star ticks, a tick survey done in Missouri 
and Kansas in 2006 found that greater than 90% of A. americanum pools were positive for 
R. amblyommii [21].  In studies in North Carolina and Tennessee, R. amblyommii was found 
in 40-56% of lone star ticks [23, 43, 44].  Initial studies of R. amblyommii in voles and guinea 
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pigs determined that the bacteria was nonpathogenic, and for many years it was assumed 
that it was nonpathogenic for humans as well [42, 45].  More recent studies have provided 
some evidence that R. amblyommii may cause a mild rickettsiosis in humans.  Sanchez et al 
[46] conducted a seroepidemiologic investigation of military personnel from a unit who had 
trained in Virginia and Kansas, after which two cases of tick-borne illness had been 
reported.  Post-exposure sera was collected from the 109 individuals from that unit and 18 
had elevated (≥1:64) titers against R. rickettsii, but only 33% reported a febrile illness.  A 
subsequent reevaluation of the sera from 12 of those individuals showed that 5 of those 
sera had a greater specificity to R. amblyommii antigen than to other species of SFGR 
tested by Western blotting [47].  Billeter et al [16] published a report of a woman from central 
North Carolina who developed a rash after being bitten by a lone star tick that tested 
positive for R. amblyommii, no other symptoms were reported and no clinical samples were 
available to confirm the etiology of the rash.  Apperson et al [15] conducted active 
surveillance for tick-borne illnesses in a central North Carolina county in 2006.  Through 
physician-based surveillance, 16 probable cases of RMSF were identified, of which 6 had 
paired sera available.  Since initial testing failed to confirm RMSF in these patients, they 
were retested against both R. rickettsii and R. amblyommii antigens, and higher titers to R. 
amblyommii were observed for all 6 patients, and 3 were found to seroconvert against R. 
amblyommii.  The illnesses reported by these patients were relatively mild and none had the 
maculopapular or petechial rash typical of many cases of RMSF.   
c. Other SFGR found in US tick populations 
Several other species of SFGR have been found in tick populations in the US, and are 
currently considered of unknown pathogenicity for humans.  Rickettsia bellii was isolated 
from D. variabilis from Arkansas in 1966; and has since been shown to infect a variety of 
species of ticks and is broadly distributed in the US [48-50].  Rickettsia montanensis 
(formerly R. montana) was isolated from D. variabilis and D. andersoni ticks from Montana in 
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1963 [51].  This species is commonly found among Dermacentor spp. ticks across the US, 
and recent studies found R. montanensis in 10% of D. variabilis and 0.3% of A. americanum 
ticks in Tennessee and in 19.4% of D. variabilis ticks in North Carolina [23, 44].  To date the 
only evidence of human infection with R. montanensis was a child with an afebrile rash 
following the bite of an infected D. variabilis tick in Georgia [52].  The patient seroconverted 
to R. montanensis, but with a very low convalescent titer of 1:32.  Rickettsia peacockii was 
first noted by Parker and Spencer in 1925 when it was found in D. andersoni ticks in 
Montana [53] and is now considered to be a non-pathogenic endosymbiont of these ticks in 
the western US and Canada.  In 1975 Rickettsia rhipicephali was isolated from 
Rhipicephalus sanguineus ticks on dogs [54].  This species has also been isolated from 
several species of Dermacentor ticks in California, Montana, and South Carolina.  
Antibodies to R. rhipicephali have been detected in 11% of dogs in North Carolina [55], but 
no evidence of human infection with this species has yet been documented.  [19, 34].  In 
California, Rickettsia 364D has been implicated in causing an eschar associated illness 
decades after it was first identified in Dermacentor occidentalis ticks [56].    
7. Prior seroepidemiologic studies of SFGR 
In addition to the studies described above, several other investigators have compared 
serologic reactivity of patient samples against multiple SFGR antigens.  Philip et al [57] used 
IgM and IgG IFA to examine serologic responses from RMSF patients and vaccinees 
against several antigens, including R. rickettsii, R. akari, R. conorii, R. typhus, R. prowazekii, 
and R. canada.  Cross-reactions against SFGR were observed in many patients, but all 
culture confirmed RMSF patients produced the highest titers against R. rickettsii antigen.  
Cross-reaction staining characteristics varied, but the authors suggested that more sharp, 
uniform, and intense staining would likely be seen for the infecting strain than for other 
strains that have poorer staining.  A later study by the same group evaluated cross-reactivity 
of Rickettsia species by IFA in mice [58].  Mice were inoculated with 72 different strains of 
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Rickettsia, and the authors found that all strains reacted to their homologous antigen with 
the highest titer, and with homologous titers at least 4-fold greater than heterologous titers.   
Raoult and Paddock [59] evaluated 15 sera from patients that were known to be reactive 
to R. rickettsii using class-specific IFA with R. rickettsii and R. parkeri antigens.  Higher titers 
(at least 4-fold) of both IgG and IgM antibody against R. rickettsii was observed in 4 
patients, and against R. parkeri in 5 patients.  No difference in titer between R. rickettsii and 
R. parkeri antigens was observed for 6 patients.  Additional evidence of infection with R. 
parkeri was provided by Western blot analysis of the 4 patients that had higher titers against 
R. parkeri, which all reacted with a 120-kD protein of R. parkeri.  In this study only single 
samples were tested for each patient, so seroconversion could not be demonstrated, and no 
clinical information was available. 
Paddock et al [36] conducted comparative IgG and IgM serologies by IFA from 
confirmed (n=6) and probable (n=6) cases of R. parkeri rickettsiosis using R. parkeri, R. 
rickettsii, R. amblyommii, and R. akari antigens.  Paired sera were only available for some of 
the patients, so reactivity was compared using a single sample from each patient.  For 
patients with more than one sample, the first sample which gave a titer ≥ 1:64 against any 
antigen was used.  IgG geometric mean titers were higher against R. rickettsii than for any 
other antigen and were positive (≥ 1:64) for 11/12 of the patients compared to 10/12 for R. 
parkeri, and 8/12 for R. amblyommii and R. akari antigens, although these differences were 
not statistically significant. IgM geometric mean titers were highest against R. parkeri 
antigen, with 9/12 patients positive for R. parkeri, 8/12 for R. rickettsii, 7/12 for R. akari, and 
5/12 for R. amblyommii (which was the only statistically significant result).  Therefore, 
comparing single IFA titers from patients with suspected SFGR infections is unreliable for 
identification of the etiologic agent. 
In conclusion, it is clear that while R. rickettsii is still circulating and causing disease 
among people living in the southern and southeastern US, that people are also being 
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exposed to and infected by other SFGR carried by tick species in these regions.  Some of 
these SFGR have been shown to cause human disease (such as R. parkeri), while the 
pathogenic potential of others has yet to be determined (such as R. amblyommii).  The fact 
that the large majority of patients are diagnosed with RMSF (or a SFGR infection) using 
serologic methods with only R. rickettsii antigen combined with the fact that there is 
serologic cross-reactivity between species of SFGR makes it difficult to determine which 
agent(s) are responsible for the cases being reported.  Until new diagnostic methods are 
developed which can distinguish between species of SFGR, or the use of molecular 
methods becomes more popular, the relative contributions of different species of SFGR to 
human morbidity will remain unclear.  Prospective studies of patients with suspected tick-
borne illness which include paired serologies, molecular detection and culture from whole 
blood and skin biopsies are needed to determine the etiologies of SFGR infections in this 
region.  Unfortunately these types of studies would require significant effort and funds to 
identify a sufficient number of patients and to obtain the necessary clinical specimens within 
the critical window of time after onset.  While it cannot ascertain etiology, a retrospective 
analysis using species specific IFA on paired sera from patients with suspected RMSF is a 
simple and inexpensive alternative that may shed some light on this issue. 
B. Tick bite prevention among outdoor workers 
1. Risk of tick bites and tick-borne diseases among outdoor workers 
The growing problem of tick-borne diseases in the US is particularly a concern for 
people who have frequent and unavoidable exposure to tick infested habitats because of 
their occupation.  The National Institute for Occupational Safety and Health (NIOSH) lists 
several occupational groups who are at risk for tick-borne diseases including construction 
workers, landscapers, forestry workers, brush clearers, land surveyors, farmers, railroad 
workers, oil field workers, utility line workers, and parks and wildlife management workers 
[60].  Although there is very little published information on the frequency of tick bites among 
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populations of outdoor workers, from the few studies which collected information on tick 
exposure it appears that many outdoor workers are exposed to ticks on a daily basis and 
tick bites are relatively common.  A study of employees of the New Jersey Department of 
Environmental Protection and Energy (primarily outdoor workers) found that almost half of 
the study participants reported finding ticks on their skin or clothing at the end of the work 
day and had an overall mean of 3.5 (± 7.6) tick bites in the previous year, although there 
was considerable geographic variation [61].  In contrast to the paucity of data on tick bites, 
there has been a substantial amount of research focused on the occupational risk of tick-
borne disease.  There are more than 25 published studies on the risk of Lyme disease 
among outdoor workers, primarily among forestry workers, farmers, and park rangers [61-
92].  The majority of these studies found that these populations of outdoor workers were at 
increased risk for exposure to Borrelia burgdorferi, the agent of Lyme disease.  A recent 
serosurvey of National Park Service employees from the Great Smoky Mountains (in North 
Carolina and Tennessee) and Rocky Mountain National Park (in Colorado) showed that 
22% of employees were seropositive for spotted fever group rickettsia, 3% were seropositive 
for Ehrlichia chaffeensis, 8% were seropositive for Anaplasma phagocytophilum, and none 
were seropositive for B. burgdorferi [93].  Covert and Langley, provided a review of the 
literature on occupational infectious diseases among forestry workers [67].  Of the twenty 
infectious diseases covered in the review, six were tick-borne diseases, including Lyme 
disease, tularemia, ehrlichioses, rickettsial diseases, central European encephalitis, and 
babesiosis. 
2. Prevention strategies for tick bites and tick-borne diseases 
The first line of defense against tick bites and tick-borne diseases is to avoid contact with 
tick habitat during the season for peak tick activity.  For outdoor workers, this is not feasible  
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and since there are no vaccines currently available1 for any of the tick-borne diseases 
endemic to the US they must therefore rely on the use of personal protection measures to 
prevent tick bites and tick-borne disease.  The methods of tick bite prevention 
recommended by NIOSH for outdoor workers include: wearing light colored protective 
clothing (long sleeves, long pants, and hat), tucking pants into socks or boots, regular 
application of insect repellant (at least 20% DEET) to exposed skin, spraying work clothing 
with permethrin (must be reapplied after several washings), thoroughly checking your body 
for ticks every day with prompt and appropriate removal of the tick, and washing work 
clothing in hot water to kill any ticks [60].  Consistent use of these tick bite prevention 
methods has been proven effective, but there is evidence that there is poor adherence to 
these recommendations.  A study of outdoor workers employed by the state of New Jersey 
found that despite significant tick exposure in an area endemic for Lyme disease, less than 
a quarter of outdoor workers regularly practiced several of the recommended tick avoidance 
behaviors including using insect repellent on skin or clothes, tucking pants into socks, or 
wearing long sleeves in the summer [61].  Another study of federal and state employees 
with outdoor occupations in Lyme disease endemic areas of New York state had similar 
findings, where only 20% of employees reported using insect repellent on skin or clothing, 
and less than 10% tucked their pants into their socks [87].  The only tick bite prevention 
measures consistently used by the majority of outdoor workers from both studies was 
wearing long pants and checking oneself for ticks.  Among National Park Service employees 
from the Great Smoky Mountains and Rocky Mountain National Parks, less than half of 
employees reported using insect repellent while on the job, and only 9% treated their 
clothing with insecticide or repellent [93].  The need for reapplication of insect repellents  
___________________________________________ 
1A recombinant vaccine for Lyme disease was licensed by the FDA in 1998, but was 
withdrawn from the market in 2002 after slow sales due to cost (many insurance companies 
would not reimburse) and consumer concerns about the safety of the vaccine. 
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combined with concerns about the toxicity of the chemicals in the repellants is likely to 
account for much of the underuse of these preventive measures.  In addition, the 
concentration of DEET needed to prevent tick bites is much higher than required to prevent 
mosquito bites.  Poor adherence to currently available preventive measures by persons at 
high risk of tick-borne disease indicates that safer and more user-friendly tick-bite prevention 
strategies are needed.   
3. Permethrin impregnated clothing 
Permethrin [3-phenoxybenzl (1RS)-cis,trans-3-(2,2-dichlorovinyl)-2,2-
dimethylcycloprophanecarboxylate] is a synthetic chemical that is approved by the EPA for 
use as a contact repellent/insecticide for agricultural, residential, and personal use (on 
clothing only).  Permethrin has the ability to repel, knockdown, and kill many arthropod 
vectors including but not limited to ticks, mosquitoes, sandflies, fleas, and chiggers [94].  
Extensive studies on the toxicity of permethrin have shown that permethrin is safe for 
humans at exposure levels consistent with proper use of permethrin products, although toxic 
effects due to overexposure can occur through inhalation or skin contact when self-applied 
permethrin products are used improperly [94, 95].  The most commonly used form of 
permethrin for clothing treatment is a 0.5% permethrin aerosol spray commonly known as 
Permanone. Field trials evaluating the effectiveness of permethrin treated clothing using 
pressurized sprays and dipping methods have shown that permethrin can provide nearly 
100% protection against questing ticks including Amblyomma americanum [96-98], 
Dermacentor variabilis [96, 98], Ixodes scapularis [98, 99], and Ixodes pacificus [100], 
although the high rate of protection is not sustained over long periods of wear or after 
multiple washings [100, 101].  A seroepidemiologic study of military personnel exposed to 
heavily tick-infested area of Arkansas found that persons who applied permethrin products 
to their uniforms were significantly less likely to seroconvert to SFGR or Ehrlichia species 
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[102].  Spray and dipping methods for treating clothing with permethrin require regular 
reapplication by the user to maintain high levels of activity after laundering.  The need for 
reapplication and the possibility of overexposure to permethrin during the application 
process is burdensome and potentially harmful for the user, which are disincentives for the 
use of self-applied methods of permethrin treatment for clothing. 
4. Long-lasting factory-based permethrin impregnated clothing 
In recent years, factory-based methods for permethrin impregnation of clothing have 
been developed which allow clothing to retain long term insecticidal activity.  Insect Shield, 
LLC, a company based in Greensboro, NC, has developed a process which combines 
factory-based technology with a proprietary formulation of permethrin that allows clothing to 
retain effective repellent activity for over 70 washes (the effective lifetime of a garment).  
Clothing treated by Insect Shield has undergone extensive safety testing and has been 
approved by the EPA for use among people of all ages, including pregnant women and 
children [103].  Insect Shield treated clothing is commercially available and is sold by 
several well-known outdoor marketers such as LL Bean and Orvis, and is a key component 
of the Department of Defense Insect Repellent System.  Because the permethrin is very 
tightly bound to the fabric, there is less dermal absorption of permethrin as compared to 
clothing treated using spray or dipping methods and less contamination of waste water 
during laundering [103-105]. The use of permethrin impregnated uniforms for high-risk 
outdoor workers could be a simple, safe, and cost-effective method to reduce tick bites and 
exposure to tick-borne diseases.   
5. Safety of Insect Shield permethrin impregnated clothing 
The Insect Shield garment treatment is regulated by the US EPA which reviews 
repellents to meet their standards for safety and efficacy prior to issuance of the registration 
required to allow such products to be sold in the US. Insect Shield received the first ever 
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EPA registration for insect repellent apparel in 2003.  When registering a pesticide, the EPA 
identifies four levels of toxicity for the product and requires an associated Signal Word on 
the label for all but Toxicity Category IV, the most favorable of the categories. Insect 
Shield apparel is in this most favorable category IV and accordingly requires no Signal 
Word on its labeling.  In addition to meeting EPA standards for safety, Insect Shield 
conducted its own human biomonitoring study to determine the relative level of safety on the 
Insect Shield products compared to self-applied permethrin products. The results showed 
a level of safety two orders of magnitude safer than the standard used by the EPA [106]. 
6. Efficacy of factory-based permethrin impregnated clothing 
a. Knockdown testing  
Knockdown testing is a widely accepted scientific laboratory methodology for 
determining the efficacy of insect repellent-treated clothing and measures the sublethal 
incapacitation of insects upon exposure to treated fabric.  Knockdown testing of Insect 
Shield permethrin impregnated clothing against two tick species, Rhipicephalus 
sanguineus and Ixodes scapularis, was performed by an independent laboratory, with ten 
replicates at each wash level [107].  The results of the testing showed that the treated 
clothing has a 90.4% and 100.0% knockdown rate within 60 minutes of exposure for R. 
sanguineus and I. scapularis after 80 washings, respectively (Figure 4).  All samples tested 
against I. scapularis resulted in 100% knockdown within 15 minutes.  In a comparison of the 
longevity of knockdown activity against Aedes aegypti mosquitoes, Insect Shield treated 
clothing retained over 80% knockdown activity after 80 washes, while Permanone sprayed 
clothing had 55% knockdown activity after only 5 washes.  Since ticks are more sensitive to 
permethrin than mosquitoes [94], it is likely that the contrast in longevity between 
Permanone sprayed clothing and Insect Shield impregnated clothing is even more 
dramatic for tick species.  These results indicate factory-based long lasting permethrin 
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impregnated clothing is highly effective as a tick repellent in a controlled laboratory setting 
and is likely to provide a high level of protection against tick bites in the field for significantly 
longer durations than for self-applied permethrin products. 
    
Figure 4. Percent knockdown at 60 minutes for Insect Shield treated fabric (50% cotton, 
50% nylon).  [107] 
 
b. Tick attachment studies 
Two studies have evaluated the efficacy of factory-based permethrin-impregnated 
clothing for prevention of tick attachment.  In a study by Faulde et al [108], six subjects were 
exposed to tick-infested areas in the mountains of Germany for a total of 36 person-hours, 
during which each subject wore permethrin impregnated fabric on one leg and untreated 
fabric on the other leg.  As the subjects walked through the woods, the fabric was examined 
every 5 minutes and any attached ticks were removed and collected.  Only 6 ticks were 
found attached to the permethrin impregnated fabric, compared to 132 ticks attached to the 
untreated fabric, which corresponded to a 95.5% protection rate against questing Ixodes 
ricinus ticks for the permethrin impregnated fabric.  A small clinical trial assessing the 
efficacy of self-applied permethrin and factory-based permethrin impregnated casual 
summer clothing (sneakers, socks, shorts, and t-shirt) for the prevention of tick attachment 
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was conducted in an indoor setting in which volunteers were artificially infested with 30 
nymphal Ixodes scapularis ticks and any attached ticks were counted and removed after 2.5 
hours [109].  Subjects wearing permethrin treated clothing were 3.4 times less likely to have 
ticks attach to their body than subjects wearing untreated clothing.  Those wearing 
commercially treated clothing had fewer attachments than those wearing self-applied 
permethrin, but the difference was not statistically significant. 
7. Evaluating the effectiveness of long lasting permethrin impregnated clothing 
The effectiveness of long lasting permethrin impregnated uniforms against ticks over an 
extended period of time under actual field conditions has not previously been evaluated.  
We anticipate that the results of a randomized-controlled trial will show that the use of long 
lasting permethrin impregnated uniforms can significantly reduce the number of tick bites 
sustained by outdoor workers as compared to existing tick bite prevention methods.  As an 
improved method of tick bite prevention that is simple, safe, and user-friendly, permethrin 
impregnation of uniforms would likely to appeal to employers who are concerned about the 
risk of tick bites and tick-borne diseases among their employees who are frequently 
exposed to tick-infested habitats.  If permethrin impregnation of uniforms is implemented as 
a standard safety policy for outdoor workers the public health benefits would extend not only 
to outdoor workers but to the environment by the decreased use of self-applied permethrin 
products which are readily leached into wastewater after laundering. 
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Chapter 3 
PRELIMINARY STUDIES 
A. Occupational tick bite logs 
Several divisions within the North Carolina Department of Environment and Natural 
Resources (NCDENR) and the North Carolina Department of Transportation (NCDOT) have 
instituted a tick bite reporting policy in order to collect information on the frequency of tick 
bites among employees.  The use of these “tick bite logs” was motivated by the difficulties in 
obtaining workers compensation after developing medical complications due to tick bites.  
The tick bite logs are intended to serve as a mechanism to confirm an employee’s 
occupational tick bite history in the event of a tick bite related medical claim.  Employees are 
asked to report all tick bites to their supervisor, which are recorded in monthly tick bite logs.  
The Location and Surveys Unit of the NCDOT was the first division to implement this policy 
due to the high level of exposure to ticks among field staff and the presence of a highly 
motivated safety officer.  All tick bite logs from 2006 through 2008 were requested from 
NCDOT Locations and Survey Unit field offices, and data was available for five of the 
thirteen field offices.  Table 1 shows the descriptive statistics by year for all tick bites 
reported between 2006 and 2008 among employees of these five offices (from a total of 
approximately 40 employees). 
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 2006 2007 2008 2006-2008 
(Cumulative) 
Total tick bites 115 72 77 264 
Mean* 4.3 2.5 2.7 3.1 
Standard deviation* 4.6 2.8 2.7 3.5 
95% CI (Poisson distribution) 3.5, 5.1 1.9, 3.1 2.1, 3.3 2.7, 3.5 
Range* 1 - 24 1 - 14 1 - 11 1 - 24 
* Tick bites per employee among employees who reported at least one tick bite. 
Table 1.  Tick bite log data from Locations and Survey Units, NCDOT, 2006-2008. 
The peak season for tick bites was consistent across all three years, with most tick bites 
reported between April and August (Figure 5).  We chose study periods of March through 
September for our study to ensure that we will capture the majority of the active tick season, 
including an extra month at the beginning and end of the peak season in the case of an 
early or delayed tick season in the study years. 
 
Figure 5.  Number of tick bites reported by Locations and Surveys Unit of NCDOT by week, 
2006-2008. 
 
Information on the location of the tick bite(s) on the body is also collected on the NCDOT 
tick bite logs.  For all tick bites reported between 2006 and 2008, 11% of bites were on the 
head or neck, 12% of bites were on the arms, 17% of bites were in the groin area or on the 
buttocks, 26% of bites were on the legs, and 34% of bites were in the midsection area 
(chest, waist, and back).  These data show that the majority of tick bites take place in areas 
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that are covered by clothing.  Using barrier methods such as tucking pants into socks or 
boots may prevent many ticks from getting inside pant legs, but previous studies of outdoor 
workers have shown that only a small percentage practice this method on a regular basis 
[61, 87].  The use of permethrin impregnated clothing is an alternative strategy that can 
prevent ticks from getting underneath clothing by immobilizing (and then killing) any ticks 
that come into contact with treated clothing.   
The North Carolina Division of Parks and Recreation (NCDPR) and the North Carolina 
Division of Forest Resources (NCDPR), two of the sources of the study population for our 
study, began implementation of the tick bite reporting policy in 2008.  The tick bite log data 
for 2008 was requested from all state parks and county level forest service offices.  NCDPR 
2008 tick bite log data was compiled by state park and the mean number of tick bites per 
employee was calculated for each park.  The density of tick bites by park was mapped and 
is displayed in Figure 6a.  Similarly, the 2008 tick bite log data from the NCDFR was 
compiled by county and the mean number of tick bites per county is shown in Figure 6b. 
Data was unavailable for some NCDFR county offices where the reporting policy had not yet 
been fully adopted (counties displayed in white).  Both maps indicate the low incidence of 
tick bites in the western part of the state, which is consistent with the low rates of tick-borne 
disease in this region.  Based on this information we chose to limit our study area to the 
eastern and central parts of the state, corresponding to NCDFR regions 1 and 2, where the 
incidence of tick bites is highest.  The overall mean number of tick bites per employee for 
NCDPR employees and NCDFR employees within regions 1 and 2 for 2008 was 3.1 and 
5.6, respectively. 
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Figure 6.  Mean number of tick bites per employee, 2008.  (a)  Tick bites reported for each 
state park for employees of the North Carolina Division of Parks and Recreation.  (b)  Tick 
bites reported by county for employees of the North Carolina Division of Forest Resources.  
Data was unavailable for counties in white.  
 
B. North Carolina state employee workers compensation claims related to tick bites 
Given the large number of tick bites sustained by North Carolina state employees who 
perform outdoor work, we were interested in the financial cost of these tick bites and 
associated illnesses.  We requested workers compensation claim data that included the 
28 
 
work “tick” in the claim from 2004-2009.  Over the six year period there were 147 claims 
related to tick bites, with a total payout of over $114,000 (Table 2).  Of note, in 2008 and 
2009 a much lower percentage of claims were paid, which motivated the implementation of 
the tick bite logs across many of the divisions in DENR.  Overall these claims are likely to 
grossly underestimate the true “cost” of tick bites among outdoor workers in North Carolina, 
as it is likely that many employees who seek treatment following a tick bite do not file a claim 
(personal communication, Chuck Stanfill, DENR Safety Director).  Further studies are 
needed to estimate the medical costs and lost work time due to tick bites and related 
illnesses. 
Year 
 Tick 
related claims 
Tick related 
claims paid 
Total 
payout 
2004 19 14 $28,841 
2005 29 25 $34,643 
2006 20 16 $10,824 
2007 38 29 $36,786 
2008 22 9 $1,699 
2009 
(thru 9/9/09) 19 8 $1,286 
TOTAL 
(2004-2009) 147 101 $114,079 
 
Table 2.  North Carolina state employee workers compensation tick-related claims 2004-
2009. 
 
C. Pilot study: Effectiveness of long-lasting permethrin-impregnated clothing for the 
prevention of tick bites 
In 2009, we conducted a nonrandomized open label pilot study to determine the 
effectiveness of Insect Shield treated clothing for the prevention of tick bites among 
sixteen outdoor workers from the North Carolina Division of Water Quality [110]. Treatment 
status was self-selected, all subjects chose whether to have their clothing treated with 
permethrin or to serve as “controls”.  Subjects who chose to be in the treatment group were 
asked to submit all items of clothing normally worn while performing field work , including 
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shirts, pants, socks, hats, and boots.  All subjects were instructed to launder their clothing as 
they normally would and to continue with their normal tick bite prevention measures, 
regardless of their treatment status.   
Participants completed questionnaires at the start of follow-up (March 2009) and at the 
end of follow-up (September 2009), and tick bites and outdoor work hours were reported on 
weekly tick bite logs for the entire follow-up period.   During the follow-up period there were 
68 tick bites reported by the subjects in the control group (mean=9.7 bites per subject), and 
6 tick bites reported by the subjects in the treatment group (mean=0.7 bites per subject) 
(Figure 7).  Crude incidence rates and incidence rate ratios were computed using negative 
binomial regression.  Subjects wearing Insect Shield treated clothing had a 93% reduction 
(p<0.0001, 2-tailed Chi-square test) in the total incidence of tick bites compared to subjects 
using standard tick bite prevention measures (Table 3).  This pilot study provides preliminary 
evidence that long-lasting permethrin-impregnated clothing may be highly effective against 
tick bites.   
 
Figure 7.  Mean number of tick bites by treatment group, including total, work related, or 
non-work related tick bites from a pilot study on the effectiveness of Insect Shield treated 
clothing for the prevention of tick bites [110].  
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Tick Bite Rate 
IRR* (95% CI†) p-value Control 
Group 
Treatment 
Group 
Total 
(per 100 outdoor hours) 
2.32 0.16 
0.07 (0.02, 
0.24) 
<0.0001 
Work Related 
(per 100 outdoor work hours) 
4.68 0.05 
0.01 (0.001, 
0.11) 
<0.0001 
Non-work Related 
(per 100 outdoor non-work 
hours) 
0.73 0.31 
0.42 (0.10, 
1.79) 
0.24 
*IRR: Incidence rate ratio 
†CI: Confidence interval 
 
Table 3.  Estimates of tick bite incidence rates and incidence rate ratios from a pilot study on 
the effectiveness of Insect Shield treated clothing for the prevention of tick bites [110].
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Chapter 4 
RESEARCH DESIGN AND METHODS 
 
A. Seroepidemiology of spotted fever group rickettsiae in North Carolina 
1. Selection of case patients 
Case patients were identified from a database of patients who were tested for RMSF at 
the North Carolina State Laboratory of Public Health, between 2008 and 2010.  This 
database included any patients for which sera had been submitted for serologic testing 
against R. rickettsii, which does not necessarily mean they had symptoms of RMSF, but just 
that their physician ordered the test.  All sera submitted to the NCSLPH serology unit are 
retained and stored at -20 ºC for up to 3 years, so all patients listed in the database for 
which sera was available at the time of the study were candidates for inclusion in the study. 
Eligibility criteria for inclusion in the study population consisted of: 
 Having been tested for RMSF by IFA at the NCSLPH between 2008 and 2010 
 Availability of paired sera (acute and convalescent) 
 At least one of the sera had a titer ≥ 1:64 against R. rickettsii  
Patients were excluded from the study if there was only a single serum specimen 
available, if there was not sufficient sera remaining for additional testing, or if the sera could 
not be located. 
2. Indirect Immunofluorescence Assay (IFA) 
The IFA was conducted according to the protocol used by the Centers for Disease 
Control and Prevention [111], with minor modifications as per the recommendations of the 
staff of the special serology unit at the NCSLPH.  All testing was completed by trained staff 
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at the NCSLPH, as well as myself, after completing training by Gaylen Daves, the senior 
technician of the special serology unit. 
a. Preparation of antigen slides 
R. rickettsii, R, typhi, R. parkeri, and R. amblyommii antigens were provided by William 
Nicholson, Rickettsial Zoonoses Branch, CDC.  Frozen lyophilized antigen was 
resuspended sterile deionized distilled water.  Antigen was spotted onto the wells of glass 
templated slides using capillary tubes.  Each divided well was spotted with either R. typhi 
and R. rickettsii, or R. parkeri and R. amblyommii, to allow for side by side comparison of 
fluorescence and staining patterns.  Antigens spots were allowed to air dry and then fixed in 
acetone for 15 minutes at room temperature.  Slides were then stored in sealed boxes at -70 
ºC until they were ready to be used. 
b. Sample preparation and dilution 
Frozen slides were placed at room temperature and allowed to warm while serial 
dilutions were being made.  Dilutions were prepared in u-bottom 96-well microplates.  The 
primary dilution of 1:64 was prepared in 3% egg yolk for the R. rickettsii antigen and 1% 
bovine serum albumin (BSA) in phosphate buffered saline (PBS) for R. parkeri, R. 
amblyommii, and R. typhi.  Remaining serial two-fold dilutions were made in PBS with 1% 
BSA for all antigens.  Sera were diluted to a final dilution of 1:2048, except for positive 
control sera, which were diluted to 1:16384.  Dilutions were applied to the slides and 
incubated in a humid chamber at 37 ºC for 30 minutes.  Slides were rinsed in PBS, washed 
in PBS for 10 minutes, and washed in distilled water for 10 minutes, and air dried.  
Fluorescein isothiocyanate (FITC)-labeled goat anti-human IgG conjugate (Scimedx, 
Danville, NJ) with Eriochrome black counterstain was applied to each well and incubated in 
a humid chamber at 37 ºC for 30 minutes.  Slides were washed as described above and 
once dried a drop of buffered glycerol was added to each well and overlaid with a coverslip.  
Slides were stored in the dark until they were read (within 4 hours).   
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c. Reading slides and interpretation of results 
Slides were read on a UV epifluorescence microscope, and wells were initially examined 
at low power (100x) and then high power (400x).  After reading the negative control wells, 
the positive control and test samples were read from highest dilution to lowest dilution.  
Fluorescence was scored according to brightness and consistency of staining throughout 
the well on a scale of 4+, 3+, 2+, 1+, +/-, and -, with 4+ being the most intense fluorescence.  
Endpoint titers were recorded as the reciprocal of the dilution with 1+ fluorescence.  If 
staining intensity did not increase as expected from higher dilutions to lower dilutions or if 
non-specific staining of the egg yolk, cytoplasm, or nucleus was observed, then non-specific 
staining was noted and no endpoint titer could be determined.  Staining for negative controls 
was confirmed by the absence of specific fluorescence (either +/- or -).   Digital photos were 
taken of a small subset of samples to illustrate the fluorescence patterns that were observed 
for each antigen. 
d. Quality control 
The assays were performed in a CLIA certified laboratory, by trained technicians.  
Positive control sera from a patient with a known titer against R. rickettsii antigen was 
included in each run (including dilutions from 1:64 to 1:16384).  Slides for which the positive 
control was within one dilution of the known titer were considered acceptable.  There were 
no positive control sera available for R. parkeri or R. amblyommii, so the positive control 
sera for R. rickettsii was used on these slides.  All sera were also tested against R. typhi (as 
per standard procedure) to rule out that the patient had been exposed to a typhus group 
rickettsia.  Negative controls, including PBS only, PBS with BSA and a negative control sera 
that is non-reactive to R. rickettsii (primary dilution only) were also included in each run.  If a 
slide showed any reactivity in the control wells the assay was considered invalid and was 
repeated.  Paired sera were always tested together, in the same set of samples, by the 
same technician.  If a sample had a questionable result or if problems with the staining were 
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noted, the senior technician reevaluated the slide and either made the final call on the 
endpoint titer or noted there was nonspecific staining, or suggested that the test be 
repeated.  If a test needed to be repeated, both samples (acute and convalescent) were 
repeated together.  For samples with a high level of debris or filmy appearance, the sera 
were centrifuged at 10,000 RPM for 5 minutes and/or heat inactivated for 30 minutes at 56 
ºC, and the assay was repeated.  For samples that did not give a titer against R. rickettsii 
that was within one dilution of the original titer, the assay was repeated and the titer that was 
found in the majority of the assays was accepted as the correct titer. 
3. Surveillance reports 
In North Carolina, when a patient tests positive against R. rickettsii antigen it is required 
that the results are reported to the NC Division of Public Health, and in each case, an effort 
is made by the state vector-borne nurse consultant to collect relevant clinical data from that 
patient to determine if that patient meets the case definition for “Spotted Fever Group 
Rickettsiosis (including Rocky Mountain spotted fever)”.  In some cases a public health 
nurse will interview the patient or health care provider who saw the patient, in some cases 
the medical record is reviewed, and other cases no information other than the laboratory 
report is available.  Surveillance reports from the NC Division of Public Health (NCDPH) 
were requested for all patients included in this study.  Sample numbers from the NCSLPH 
were cross-referenced with event numbers in the North Carolina Electronic Disease 
Surveillance System (NCEDSS) and all available reports were provided in paper format 
(deidentified).  A form was created in Qualtrics and relevant fields were entered into the form 
for each patient.   
a. Variables  
The variables were created based on part 2 of the communicable disease report for 
Rocky Mountain spotted fever (Appendix A) and modified as needed to reflect the new 
electronic reporting format and response options.  The variables are listed in Table 4. 
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Variable Type 
DEMOGRAPHIC INFORMATION  
Age Continuous 
Gender Binary 
Race Nominal 
Ethnicity Nominal 
CLINICAL INFORMATION  
Patient symptomatic? Binary 
Symptoms/clinical findings 
     Fever 
     Headache 
     Myalgias 
     Skin rash 
     Fatigue/malaise/weakness 
     Chills/rigors 
     Nausea 
     Vomiting 
     Meningitis 
     Encephalitis 
     Acute renal failure 
     Thrombocytopenia 
     Leukopenia 
     Anemia 
     Elevated liver enzymes 
 
Binary 
Binary 
Binary 
Binary 
Binary 
Binary 
Binary 
Binary 
Binary 
Binary 
Binary 
Binary 
Binary 
Binary 
Binary 
Took antibiotics for illness? Binary 
Patient hospitalized? Binary 
Discharge/final diagnosis Nominal 
Died from illness? Binary 
SOURCE INFORMATION  
Patient interviewed? Binary 
Health care provider(s) consulted? Binary 
Medical record reviewed? Binary 
 
Table 4.  Variables abstracted from surveillance reports of patients tested for R. rickettsii by 
IFA at the NCSLPH. 
 
4. Outcome definition: seroconversion 
A seroconversion was defined as a four-fold or greater change in IgG titer against an 
antigen between acute and convalescent samples.  This includes not only a four-fold 
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increase but also a four-fold decrease in titer, which can occur when the acute sample is 
drawn later after the onset of illness at the peak of IgG production.  For each antigen, the 
patient was classified as either a seroconversion, stationary titer (lack of four-fold or greater 
change in titer), or unknown (if one or more of the samples had non-specific fluorescence or 
was unreadable).  
5. Sample size 
IFA results from patients in the NCSLPH database that had been tested for RMSF 
between 2008 and 2010 who had at least two sera tested (n= 311) were reviewed.  Of these 
patients, 126 (40.5%) had at least one sample with a titer of ≥1:64.  Eight samples could not 
be located, so those eight patients were excluded, leaving 118 patients in the study.  
Surveillance reports were available for approximately half of the patients. 
6. Human subjects 
This research was approved by the Institutional Review Board at the University of North 
Carolina at Chapel Hill.  The use of the data was approved by the North Carolina Division of 
Public Health through a Data Use Agreement with Meagan Vaughn and Steven Meshnick.  
Since all data are deidentified, informed consent was not necessary as the risk to subjects 
was minimal. 
7. Data analysis 
a. Frequency of seroconversions 
Standard descriptive statistics were calculated for demographic and clinical variables.  
Our principal interest was the frequency of seroconversions against each antigen.  Patients 
who had an unknown outcome for any of the antigens were excluded from the analysis.  
With three antigens, there are seven possible combinations of seroconversion (excluding 
those patients who had stationary titers against all three antigens).  Each patient who 
seroconverted to at least one antigen was classified into one of the possible outcomes listed 
in Table 5.  A table and 3-way quantitative Venn diagram were created to illustrate the 
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degree of cross-reactivity and individual reactivity between the antigens.  Positive percent 
agreement and negative percent agreement were calculated for R. parkeri and R. 
amblyommii using seroconversion against R. rickettsii as the referent comparison.   
Outcome Antigen(s) 
1 R. rickettsii 
2 R. parkeri 
3 R. amblyommii 
4 R. rickettsii and R. parkeri 
5 R. rickettsii and R. amblyommii 
6 R. parkeri and R. amblyommii 
7 R. rickettsii, R. parkeri, and R. amblyommii 
 
Table 5.   Possible seroconversion outcomes for each patient, excluding patients who had 
stationary titers against all three antigens. 
 
b. Comparison of clinical profiles 
Based on the theory that many patients in North Carolina are being infected with non-
pathogenic or less pathogenic species of rickettsiae, I hypothesized that patients who 
seroconverted to R. parkeri and/or R. amblyommii had a less severe illness than those who 
seroconverted to R. rickettsii.  Unfortunately, there was insufficient clinical data to make 
useful comparisons.  Instead, the clinical profiles for the 12 patients with clinical data who 
seroconverted to at least one antigen are presented in a line listing. 
B.  Permethrin impregnated uniforms for tick bite prevention among outdoor workers 
The design for this study is a double-blind randomized controlled trial.  The study was 
conducted for 2 tick seasons (19 months, March, 1, 2011 through Sept, 30, 2012).  
Participants were randomized into two groups, the treatment group and the control group.  
Uniforms were collected from all participants, but only the uniforms from members of the 
treatment group were factory-impregnated with permethrin.  All participants were asked to 
record any tick bites during the study period on weekly tick bite logs.  Questionnaires were 
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administered to all participants at the start and end of the study period which collected 
general information on tick exposure and tick prevention practices. 
1. Study population 
The study population includes employees of the NC Division of Forest Resources 
(NCDFR), the NC Division of Parks and Recreation (NCDPR), NC Wildlife Resources 
Commission (NCWRC), and NC County and Local Parks and Recreation (NCCLPR).  The 
NCDFR has offices in nearly all of the 100 counties in North Carolina, as well as 13 district 
offices and 3 regional offices.  We recruited NCDFR employees who are based in regions 1 
and 2, which correspond to the piedmont and coastal regions of the state.  Employees from 
region 3 (the mountain region of the state) were not included in this study due to the low 
number of tick bites reported from that region.  The NCDPR has staff at each of the 34 state 
parks and the 4 state recreation areas. We recruited employees from state parks that lie 
within the boundaries of the NCDFR regions 1 and 2, which includes 26 of the 38 state 
managed parks.  The NCWRC has offices throughout the state including approximately 50 
employees in the piedmont and coastal areas.  Eligibility criteria included being over 18 
years of age, spending an average of 10 or more hours of outdoor work per week during tick 
season, having to wear a uniform while on the job, and completion of written informed 
consent.  Exclusion criteria included pregnancy or a planned pregnancy during the follow-up 
period (since exposure to an insecticide is involved), non-English speakers, or having a 
known allergy to insecticides. 
This population was selected for this study because the work duties for most employees 
of these agencies put them in direct and frequent contact with tick-infested habitats, and 
thus represent a highly exposed occupational group for tick bites.  In addition, most 
employees of these agencies are required to wear a uniform, which provided a logistical 
advantage for the study as it was possible to treat the entire set of uniforms owned by each 
participant, thus ensuring consistent use of the product throughout the study. 
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a. Recruitment and retention 
From the personnel database provided by NCDENR, all potential study participants from 
NCDFR and NCDPR were sent preliminary announcements with information about the study 
by email.  Informational meetings were conducted at local and regional offices and parks 
throughout the study area between October 2009 and April 2010.  Eligible employees were 
invited to enroll in the study at the informational meetings.  Female employees who were 
interested in participating in the study were screened for pregnancy by self-report, and were 
offered a free pregnancy test.  Upon enrollment into the study, subjects were given a small 
LED flashlight and 6 pairs of boot socks as a token of appreciation for their participation.  
Participants who completed the first year of follow-up were given an additional 6 pairs of 
boot socks as an incentive to complete the final year of follow-up. 
2. Study protocols 
a. Baseline questionnaire 
After completing the informed consent process, study participants were asked to 
complete either a paper or web-based questionnaire which collected demographic and 
occupational information, history of tick-bites and tick exposure in the past year, history of 
tick-borne disease, and use of tick-bite prevention measures (Appendix B). 
b. Randomization 
Subjects were assigned a study ID number upon enrollment.  Block randomization using 
block sizes of six generated through random numbers by computer was used to ensure the 
treatment and control groups had approximately equal numbers of participants in each 
group.  The randomization list was released to the study investigators after all tick bite log 
data collection was completed in November 2012. 
c. Collection and processing of uniforms 
Subjects were asked to write their name on all of their work uniforms with a laundry pen.  
Given that it took several weeks week to ship, treat, and return the uniforms to each subject, 
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it was impossible to treat the entire set of uniforms for each subject at one time because 
they need to have a set of uniforms to wear while the other sets were being treated.  Thus, 
the treatment process was conducted in two stages.  Subjects were asked to send half of 
their spring/summer work uniforms, including overshirts, t-shirts, pants, shorts, hats, and 
socks directly to the Insect Shield facility in Greensboro, NC.   Each shipment included a 
packing list that listed the number and type of garments included.  Once the clothing was 
received at Insect Shield, all items of clothing were labeled with a small heat sealed label 
with the subject’s ID number to ensure proper processing and return to their owner.  After 
determining the assigned treatment group for that identification number according to the 
randomization list, the clothing was either treated with permethrin according to Insect 
Shield’s patented process (treatment), or was simply washed and dried in a commercial 
washer/dryer (control).  Clothing was folded and bagged by ID number, after which it was 
shipped back to the subject.  The same process was repeated (using the existing treatment 
assignments) for any remaining items sent by the subject.  Since many subjects ordered 
new uniforms during the study period, subjects were provided with shipping materials and 
instructed to send all new uniforms items to Insect Shield before wearing them.  Clothing 
treated using Insect Shield technology has no odor, texture, or any other characteristic that 
would allow treated clothing to be distinguished from untreated clothing, thus subjects were 
blinded to their treatment status. 
d. Tick bite logs 
During the follow-up period, all subjects were asked to keep a diary of all tick bites 
(attached or embedded ticks) which were recorded on weekly tick bite logs (Appendix C).  
Upon enrollment each subject was provided with either blank paper tick bite logs (to be 
submitted by mail) or a blank electronic tick bite log (to be submitted by email).  For each 
entry in the log, subjects recorded the date of the tick bite(s), the number of tick bites, the 
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location of the tick bites on the body, the county where the tick bite(s) were most likely to 
have been acquired, whether they were on the job when the tick bite(s) were acquired, 
whether they had been using insect repellent at the time of the bite(s) and the type of 
repellent, and whether the tick(s) were collected.  If there were no tick bites during a week, 
there was a checkbox to indicate that there were no tick bites.  Subjects were also asked to 
record the number of work related and non-work related hours spent outdoors each week, 
which provided an estimate of the amount of potential exposure a subject had to tick-
infested areas.  At the end of each month subjects were asked to submit all tick logs from 
that month to the study investigators by mail or email.  Email reminders were sent to all 
subjects the day that the tick bite logs were due (the first day of the month).  If a subject did 
not submit their tick bite logs within one week of the reminder email then a second reminder 
email was sent. 
e. Follow-up questionnaires 
At the end of the first and second years, all subjects were asked to complete a follow-up 
questionnaire.  These questionnaires were similar to the baseline questionnaire, but asked 
questions about work habits, tick exposure, and use of tick bite prevention measures during 
the study period.  These questionnaires also asked about frequency of bites from 
mosquitoes, chiggers, and midges.   
3. Outcome assessment 
The incidence of tick bites was assessed using the data collected from the tick bite logs.  
To ensure that only attached ticks were reported on the tick bite logs, participants were 
instructed to report tick bites in which the tick was found attached to or embedded in the 
skin.  Subjects were instructed that unattached ticks found crawling on the body did not 
need to be reported on the tick bite log.  Tick bite diaries have been used successfully in 
other studies to collect tick bite count information [112-114].  By asking participants to 
complete tick bite logs on a weekly basis, we anticipated that the more frequent reporting 
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mechanism would encourage subjects to remember to record tick bites.  Since they were 
also asked to collect all attached ticks they removed from their body and mail them to the 
entomology laboratory at North Carolina State University, we attempted to validate the 
monthly totals from the tick bite logs by comparing this to the number of ticks found in the 
collection vial for each month.   
4. Covariates 
Information on covariates that could have affected the probability of acquiring tick bites 
during the study period (other than treatment assignment) were collected in the baseline and 
follow-up questionnaires.  Variables that were evaluated as potential covariates are shown 
in Table 6. 
Variable Variable type Data source 
Age (at enrollment) Continuous Baseline questionnaire 
Gender Dichotomous Baseline questionnaire 
Race/ethnicity Nominal Year 1 questionnaire 
DENR division Nominal Baseline questionnaire 
Occupation Nominal Baseline questionnaire 
Years at current position Continuous Baseline questionnaire 
Education Nominal Baseline questionnaire 
Number of tick bites in year prior to 
enrollment 
Continuous Baseline questionnaire 
Previous diagnosis with a tick-borne 
illness 
Nominal Baseline questionnaire 
Average number of hours spent outdoors 
per week on the job 
Continuous Baseline questionnaire 
and tick logs 
Average number of hours spent outdoors 
per week (non-work related) 
Continuous Baseline questionnaire 
and tick logs 
Frequency of wearing long pants when 
working outdoors 
Ordinal Year 1 and Year 2 
questionnaires 
Frequency of wearing a long sleeved shirt 
when working outdoors 
Ordinal Year 1 and Year 2 
questionnaires 
Frequency of wearing a hat when working 
outdoors 
Ordinal Year 1 and Year 2 
questionnaires 
Frequency of tucking pants into boots or 
socks, or taping pants to boots 
Ordinal Year 1 and Year 2 
questionnaires 
Frequency of insect repellant use on the 
skin while working outdoors 
Ordinal Year 1 and Year 2 
questionnaires 
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Frequency of insect repellent use on 
clothing while working outdoors 
Ordinal Year 1 and Year 2 
questionnaires 
Frequency of checking self for ticks when 
working outdoors 
Ordinal Year 1 and Year 2 
questionnaires 
Frequency of checking self for ticks at the 
end of the work day 
Ordinal Year 1 and Year 2 
questionnaires 
Use of self-applied permethrin on clothing Dichotomous Year 1 and Year 2 
questionnaires 
 
Table 6.  Covariates to be evaluated for inclusion in multivariable regression analysis. 
5. Human subjects 
a. Human subjects involvement and IRB approval 
The study population included employees of the NC Division of Forest Resources, the 
NC Division of Parks and Recreation, NC Wildlife Resources Commission, and NC County 
and Local Parks and Recreation.  Healthy volunteers were recruited from all regional offices 
within the central and eastern regions of the state.  Subjects eligible for the study were at 
least 18 years of age, spoke English, and spent an average of at least 10 hours per week 
working outdoors.  Participants were not excluded on the basis of race, ethnicity, or gender. 
Potential participants were excluded on the basis of English-language only because the 
study resources could not provide for a translator.  Potential participants were excluded on 
the basis of age (<18 years) to assure proper understanding of the consent procedure.  
Written consent was obtained for all subjects at an enrollment meeting or by mail.  This 
research was approved by the Institutional Review Board at the University of North Carolina 
at Chapel Hill (IRB# 10-1027). 
b. Potential risks   
The risk posed to subjects in the treatment group by wearing permethrin impregnated 
uniforms is minimal.  A potential, but extremely unlikely adverse effect that could be 
observed among wearers of the permethrin impregnated uniforms was minimal skin 
44 
 
sensitivity.  As with all studies involving human subjects, there was a potential risk of breach 
of confidentiality to all subjects by participation in this study.   
c. Protection against risk    
The consent forms and tick bite logs were mailed to the subjects in envelopes that had 
no indication of the study focus.  Study subjects were emailed a link and password to 
access the web-based questionnaires, and web-based questionnaires used 128 bit SSL 
encryption to protect the privacy of the study subjects.  The investigators keep hard copies 
of data and informed consent forms in a locked file cabinet. To protect privacy, records were 
filed under code numbers rather than by name. A master list of code numbers relating the 
participant names to the codes were kept in a separate location in a locked file cabinet.  
Digital copies of data were maintained in password protected files.  Only the study 
investigators were allowed to look at the data.  If a subject experienced any adverse effects 
that they believed were related to their uniforms (for which they were blinded to the 
treatment status of), they were asked to report those adverse effects to the study 
investigators.  All participants were instructed to perform self-inspections daily and to 
remove attached ticks promptly. All subjects were also instructed to continue their usual tick-
bite preventive practices.  Participants were provided with a wallet-sized card with 
information about the symptoms of tick-transmitted illnesses and were instructed to seek 
medical attention immediately if they developed any of the symptoms.  Free medical 
attention for suspected tick-related illnesses was provided by the study physician (Dr. 
Jonathan Juliano) if requested.  If a subject saw Dr. Juliano at UNC Hospitals, all 
clinic/hospital charges for the visit and fees for his time were covered by the study.  Any fees 
for laboratory tests or treatments were borne by the subject, except for any testing 
performed by the study investigators (serology for tick-borne pathogens). 
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d. Potential benefit to the subjects and others 
The direct benefit to the subjects was the potential for decreased tick bites (and tick-
borne disease) and other insect/arthropod bites among those wearing the permethrin 
impregnated clothing.  Since subjects in the control group did not receive this benefit during 
the study period, free treatment of uniforms was offered to all control subjects at the end of 
the study.  Information gained in this study could lead to policy recommendations for outdoor 
workers on how best to prevent tick bites and tick-borne disease in this high-risk population. 
e. Data Safety and Monitoring Board (DSMB) 
According to the Dan Nelson, Director of UNC’s Office of Human Research Ethics, this 
project did not constitute a clinical trial because it did not involve “drugs, treatments, 
devices, or new ways of using known drugs, treatments, or devices” as in the NIH definition. 
Thus, a DSMB was not mandated. However, after the first year of follow-up a DSMB was 
convened (UNC TraCS DSMB) to determine whether the number of seroconversions 
observed in year 1 was possibly related to treatment status, and whether the study should 
be stopped early.  Based on the recommendation of the DSMB, the study was allowed to 
proceed as planned. 
6. Data analysis 
a. Data management and data quality 
Data from the web-based questionnaires were automatically entered into a database 
linked to the online questionnaire.  Logical checks were built into the questionnaire to 
prevent invalid entries.  Two identical databases were created for the tick logs, and study 
personnel entered data from tick bite logs into both databases, which were compared to 
ensure accuracy.  Discrepancies were resolved by examining the original written or 
electronic records.  Consistency and range checks were implemented during the data 
cleaning process, and inconsistencies or implausible values were checked by reviewing the 
original records.  
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b. Descriptive analyses 
Variables derived from the data collected in the baseline questionnaire were used to 
describe tick exposure and use of tick bite prevention practices among this group of outdoor 
workers.  Standard univariate analysis methods were used to summarize exposure and 
treatment variables and covariates, including frequencies, means, standard deviations and 
graphical methods.  This data was used to assess the comparability of the treatment and 
control groups and to determine whether randomization was successful.  T-tests were used 
to compare continuous variables including mean age, mean number of years at current 
position, mean number of outdoor hours worked per week, mean number of outdoor hours 
(non-work related) per week, and total number of tick bites in the previous year.  Chi-square 
tests (2-tailed) were used to compare proportions for categorical variables listed in Table 6.  
Any variables that showed statistically significant differences (alpha level=0.05) between the 
treatment and control groups, or were significantly associated with the tick bite incidence 
rate in the control group were to be considered for inclusion as covariates in regression 
models. 
c. Incidence of tick bites 
All analyses were conducted on an intent-to-treat basis, assuming that subjects who 
were assigned to the treatment group adhered to their assignment and wore treated study 
uniforms while on the job throughout the study period.  The start of follow-up was defined as 
the date the subject started wearing treated uniforms (either as reported by the subject or as 
determined by the date staff were instructed to switch to wearing summer uniforms).  
Person-time at risk was computed as the sum of the outdoor work hours reported by each 
subject on their tick logs between the start of follow-up and September 30th of each year.  
The incidence rate ratio (and 95% confidence interval) for tick bites comparing the treatment 
and control groups was estimated using a generalized estimating equations (GEE) approach 
for Poisson regression [115].  The use of GEE methods made it possible to account for the 
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within subject correlation due to repeated weekly measures using a working correlation 
matrix. The appropriate structure of the working correlation matrix was determined by 
examining the correlation coefficients when the model is specified using an unstructured 
working correlation matrix.  Protective effectiveness (1 – the incidence rate ratio) [116] and 
95% confidence intervals for comparing reported tick bites between the treatment and 
control groups were calculated using a generalized estimating equations (GEE) approach 
for Poisson regression. The use of GEE methods accounted for the within subject 
correlation due to repeated measures using a working correlation matrix. 
The primary interest was to evaluate the effectiveness of permethrin-impregnated 
uniforms to reduce tick-bites that were acquired while on the job (while the subject is 
wearing study uniforms), therefore we excluded any reported tick bites that the subject 
believed to have been acquired while off the job.  To determine if the effectiveness of the 
treatment wanes over time with wear and washing, we specified a priori that incidence rate 
ratios would be stratified by year of follow-up.  If necessary, any potential covariates that 
were identified in the descriptive analyses would be included in a fully adjusted model and a 
backwards elimination strategy based on 10% change-in-estimate would be used to 
determine which variables would remain in the final model.  Coding decisions for continuous 
variables were made after examining whether the variable(s) had linear or non-linear 
relationships with the outcome using graphical methods and indicator coding.  Regression 
diagnostics were implemented to assess goodness-of-fit using the quasi-likelihood 
information criterion (QIC).   
d. Missing data 
It was anticipated that some subjects would have missing tick bite logs for some months 
or would be lost to follow-up during the study period.  The GEE model assumes that missing 
observations are Missing Completely at Random (MCAR).  The missingness of data was 
assessed for all covariates listed in Table 6 to determine whether the missing data occur 
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MCAR.  Since subjects were blinded to their treatment status, informative censoring by 
treatment status was unlikely, but this was also evaluated.  We planned to implement 
multiple imputation methods if there was more than 5% missing outcome data and it was not 
MCAR.   
7. Sample size and statistical power 
To calculate the required sample size, we used the estimated mean number of tick bites 
per subject during the study period.  The mean and standard deviation for the number of tick 
bites over the study period in the control group was estimated from 2006 – 2008 tick bite 
logs from the NCDOT (Table 1).  These estimates are similar to the estimates from the tick 
bite logs NC Division of Parks and Recreation for 2008. For a 50% reduction in tick bites in 
the treatment group, we would expect to see a mean number of 3.10 tick bites per employee 
over the duration of the 2 year study period.  The statistical power to detect a 50%, 40%, 
and 30% difference in the mean number of tick bites observed per subject with a 2-sided α 
at 0.05 level over the duration of the study for sample sizes of 100, 120, and 140 subjects is 
shown in Table 7.   A total of 159 subjects were enrolled in the study, with 127 subjects 
actively participating in the study during year 1 and 101 subjects active during year 2.  Using 
the estimated difference in means, we had >90% and 88% power to detect a 50% difference 
in the incidence of tick bites in year 1 and year 2, respectively.  The power to detect a 
difference as low as 30% in the incidence of tick bites between the control group and the 
treatment group was >50% for year 1 and 47% for year 2.  
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α Sample size      
(total) 
Difference in 
means 
SD Power 
0.05 100 3.10 (50%) 4.9 0.879 
  2.48 (40%) 4.9 0.707 
  1.86 (30%) 4.9 0.466 
0.05 120 3.10 (50%) 4.9 0.930 
  2.48 (40%) 4.9 0.785 
  1.86 (30%) 4.9 0.539 
0.05 140 3.10 (50%) 4.9 0.961 
  2.48 (40%) 4.9 0.845 
  1.86 (30%) 4.9 0.606 
 
Table 7.  Statistical power based on mean differences in tick bites between treatment and 
control groups for total sample size 100, 120, and 140.
50 
 
Chapter 5 
SEROLOGICAL EVIDENCE FOR HUMAN INFECTIONS WITH SPOTTED FEVER GROUP 
RICKETTSIAE DUE TO SPECIES OTHER THAN RICKETTSIA RICKETTSII IN NORTH 
CAROLINA 
 
A. Introduction 
Rocky Mountain spotted fever (RMSF), caused by the bacteria Rickettsia rickettsii, is 
the most commonly reported fatal tick-borne disease in the US.  The incidence of spotted 
fever rickettsioses (including RMSF)  has been rising at an unexpected rate in recent years, 
from 2.5 cases per million in 2001 to 9.5 cases per million in 2011 [117].  Mounting evidence 
suggests that infections with other species of spotted fever group rickettsiae (SFGR) are at 
least partly responsible for the increasing incidence.  Serosurveys of adults and children in 
the US show that seroprevalence to R. rickettsii is between 6% and 12% [31, 32].  Since 
subclinical infection or mild infections with R. rickettsii are considered by experts to be rare 
or even non-existent, and there is cross-reactivity among SFGR in serologic tests, exposure 
to other species of SFGR could account for this relatively high seroprevalence [18].  For 
many years Rickettsia parkeri was considered to be a nonpathogenic SFGR, until it was 
isolated from a patient in Virginia in 2002 [35].  R. parkeri is now recognized as a human 
pathogen and causes a milder illness than classic RMSF, often characterized by formation 
of an eschar at the site of inoculation [19, 34].  In California, Rickettsia 364D has been 
implicated in causing an eschar associated illness decades after it was first identified in 
Dermacentor occidentalis ticks [56].   Recent studies have suggested that Rickettsia 
amblyommii, which is present in a large percentage of lone star ticks (Amblyomma 
americanum) may cause a mild rickettsiosis in humans [15, 16, 21, 23, 43, 44, 47].  In this
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study, we evaluated the reactivity of paired sera from North Carolina patients who had been 
tested for RMSF to a panel of SFGR, including R. rickettsii, R. amblyommii, and R. parkeri. 
B. Methods 
Selection of case patients 
Case patients were identified from a database of patients who were tested for RMSF at 
the North Carolina State Laboratory of Public Health, between 2008 and 2010.  Samples are 
submitted from across the entire state, with the majority from patients in the piedmont region 
(central North Carolina).  Eligibility criteria included having paired sera available (acute and 
convalescent), and at least one sample had a titer ≥1:64 against R. rickettsii in the initial 
test.  Patients were excluded from the study if there was only a single serum specimen 
available, if there were not sufficient sera remaining for additional testing, or if the sera could 
not be located. 
Antigens 
R. rickettsii, R, typhi, R. parkeri, and R. amblyommii antigens were provided by William 
Nicholson, Rickettsial Zoonoses Branch, CDC.  Frozen lyophilized antigen was 
resuspended in sterile deionized distilled water.  Antigen was spotted onto the wells of glass 
templated slides.  Each divided well was spotted with either R. typhi and R. rickettsii, or R. 
parkeri and R. amblyommii, to allow for side-by-side comparison of fluorescence and 
staining patterns.  Antigens spots were allowed to air dry and then fixed in acetone for 15 
minutes at room temperature.  Slides were then stored in sealed boxes at -70 ºC until they 
were ready to be used. 
Indirect Immunofluorescence Assay (IFA) 
All testing was conducted at the North Carolina State Laboratory of Public Health 
according to previously published methods for the IFA [118].  Briefly, frozen slides were 
placed at room temperature and allowed to warm while serial dilutions were prepared.  The 
primary dilution of 1:64 was prepared in 3% egg yolk for the R. rickettsii antigen and 1% 
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bovine serum albumin (BSA) in phosphate buffered saline (PBS) for R. parkeri, R. 
amblyommii, and R. typhi.  Remaining serial two-fold dilutions were made in PBS with 1% 
BSA for all antigens.  Sera were diluted to a final dilution of 1:2048, except for positive 
control sera, which were diluted to 1:16384.  Positive control sera from a patient with a 
known titer against R. rickettsii antigen was included in each run (including dilutions from 
1:64 to 1:16384).  Negative controls, including PBS only, PBS with BSA and a negative 
control sera that is non-reactive to R. rickettsii (primary dilution only) were also included in 
each run. Dilutions were applied to the slides and incubated in a humid chamber at 37 ºC for 
30 minutes.  Slides were rinsed in PBS, washed in PBS for 10 minutes, and washed in 
distilled water for 10 minutes, and air dried.  Fluorescein isothiocyanate (FITC)-labeled goat 
anti-human IgG conjugate (Scimedx, Danville, NJ) with Eriochrome black counterstain was 
applied to each well and incubated in a humid chamber at 37 ºC for 30 minutes.  Slides were 
washed as described above and once dried a drop of buffered glycerol was added to each 
well and overlaid with a coverslip.  Slides were stored in the dark until they were read (within 
4 hours).   
Reading slides and interpretation of results 
The North Carolina State Laboratory of Public Health utilizes a standardized reading 
system to accurately and consistently measure the intensity of fluorescence of the antigen-
antibody complex due to the subjectivity of the IFA test. Paired sera were always tested and 
read together by the same technician. Slides were read on a UV epifluorescence 
microscope, and wells were initially examined at low power (100x) and then high power 
(400x).  After reading the negative control wells, the positive control and test samples were 
read from highest dilution to lowest dilution.  Staining for negative controls was confirmed by 
the absence of specific fluorescence.  Slides for which the positive control was within one 
dilution of the known titer were considered acceptable.  Fluorescence was scored according 
to brightness and consistency of staining throughout the well on a scale of 4+, 3+, 2+, 1+, 
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+/-, and -, with 4+ being the most intense fluorescence.  Endpoint titers were recorded as 
the reciprocal of the dilution with 1+ fluorescence.  If staining intensity did not increase as 
expected from higher dilutions to lower dilutions or if non-specific staining of the egg yolk, 
cytoplasm, or nucleus was observed, then non-specific staining was noted and no endpoint 
titer could be determined.  If a sample had a questionable result or if problems with the 
staining were noted, the senior technician reevaluated the slide and either made the final 
call on the endpoint titer or noted there was nonspecific staining, or suggested that the test 
be repeated.  If a test needed to be repeated, both samples (acute and convalescent) were 
repeated together.  For samples that did not yield a titer against R. rickettsii that was within 
one dilution of the original titer, the assay was repeated and the titer that was found in the 
majority of the assays was accepted as the correct titer. 
Surveillance reports 
Surveillance reports from the NC Division of Public Health (NCDPH) were requested for 
all patients included in this study.  Sample numbers from the NCSLPH were cross-
referenced with event numbers in the North Carolina Electronic Disease Surveillance 
System (NCEDSS) and all available reports were provided in paper format (deidentified) by 
the NC Public Health Data Group.  A form was created in Qualtrics and relevant fields were 
entered into the form for each patient.  
Outcome definition: seroconversion 
A seroconversion was defined as a four-fold or greater change in IgG titer against an 
antigen between acute and convalescent samples.  For each antigen, the patient was 
classified as either a seroconversion, stationary titer (lack of four-fold or greater change in 
titer), or unknown (if one or more of the samples had non-specific fluorescence or was 
unreadable).  
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Data analysis 
Standard descriptive statistics were calculated for demographic and clinical variables.  
Positive percent agreement and negative percent agreement were calculated for each 
antigen using seroconversion against R. rickettsii as the referent comparison.  For patients 
with surveillance reports available, clinical characteristics were compared for those who 
seroconverted to R. rickettsii and those who seroconverted to R. parkeri and/or R. 
amblyommii.  All analyses were performed using SAS (version 9.2, SAS Institute Inc., Cary, 
NC, USA). 
Human subjects 
This research was approved by the Institutional Review Board at the University of North 
Carolina at Chapel Hill.  The use of the data was approved by the North Carolina Division of 
Public Health through a Data Use Agreement.  Since all data were deidentified, informed 
consent was not required as the risk to subjects was minimal. 
C. Results 
Case patients 
IFA test results from patients in the NCSLPH database with paired sera that had been 
tested for RMSF between 2008 and 2010 were reviewed (n= 311).  Of these patients, 126 
(40.5%) had at least one sample with a titer of ≥1:64.  Samples from 8 patients were no 
longer available, and 12 patients were excluded from the analysis due nonspecific 
fluorescence or an unreadable result for at least one of the antigens.  Of the 106 patients 
included in the study, surveillance reports were available for 53.  The majority of these 
patients were white males, with a median age of 50 (range 1-80) (Table 8).  The 
demographic profile was similar for patients who seroconverted to at least one of the SFGR 
antigens and patients with stationary titers.   
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Table 8.  Demographic and clinical characteristics of all patients with a surveillance record 
available, patients with a surveillance record who seroconverted to a SFGR, and patients 
with a surveillance record who did not seroconvert. 
 
Seroconversions 
Of the 106 eligible pairs tested, 10 patients seroconverted to R. rickettsii antigen in the 
original testing.  In our subsequent testing, only 8 of the 10 seroconverted to R. rickettsii 
antigen.   The two patients that seroconverted to R. rickettsii antigen in the original testing 
but did not meet the criteria for seroconversion to R. rickettsii in subsequent testing both 
produced titers that were within the one dilution allowance for intra-assay variability of the 
 All patients 
(n=53) 
Seroconverters 
(n=12) 
Non-seroconverters 
(n=41) 
DEMOGRAPHIC 
INFORMATION 
   
Age – median (range) 50 (1 – 80) 49 (1 – 70) 51 (7 – 80) 
Gender 
     Male 
     Female 
 
29/47 (61.7%) 
18/47 (38.3%) 
 
7/10 (70.0%) 
3/10 (30.0%) 
 
22/37 (59.5%) 
15/37 (40.5%) 
Race 
    White 
    Black 
    Other 
 
45/53 (84.9%) 
3/53 (5.7%) 
2/53 (3.8%) 
 
10/12 (83.3%) 
0/12 (0%) 
2/12 (16.7%) 
 
35/41 (85.4%) 
3/41 (7.3%) 
0/41 (0%) 
Hispanic Ethnicity 3/42 (7.1%) 1/11 (9.1%) 2/31 (6.4%) 
CLINICAL INFORMATION    
Symptoms/clinical findings 
     Fever 
     Headache 
     Myalgias 
     Skin rash 
     Acute renal failure 
     Thrombocytopenia 
     Leukopenia 
     Anemia 
     Elevated liver enzymes 
 
27/46 (58.7%) 
14/36 (38.9%) 
24/40 (60.0%) 
16/41 (39.0%) 
2/29 (6.9%) 
7/28 (25.0%) 
5/26 (19.2%) 
4/28 (14.3%) 
8/28 (28.6%) 
 
8/11 (72.7%) 
4/10 (40.0%) 
6/10 (60.0%) 
3/11 (27.3%) 
1/5 (20.0%) 
3/6 (50.0%) 
3/5 (60.0%) 
2/6 (33.3%) 
2/5 (40.0%) 
 
19/35 (54.3%) 
10/26 (38.5%) 
18/30 (60.0%) 
13/30 (43.3%) 
1/24 (4.2%) 
4/22 (18.2%) 
2/21 (9.5%) 
2/22 (9.1%) 
6/23 (26.1%) 
Took antibiotics for illness 36/45 (80.0%) 9/9 (100%) 27/36 (75.0%) 
Patient hospitalized 7/48 (14.6%) 2/12 (16.7%) 5/36 (13.9%) 
Died from illness 0/20 (0)% 0/5 (0%) 0/15 (0%) 
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IFA.   In our subsequent testing, one of these patients seroconverted to R. amblyommii 
antigen and the other did not seroconvert to any of the SFGR antigens.   
Overall, 21 patients seroconverted to one or more of the SFGR antigens in the testing 
performed for this study.  The frequency of seroconversions to each antigen and cross-
reactivity between antigens is depicted in Figure 8.  Of the eight patients that seroconverted 
to R. rickettsii, seven also seroconverted to both R. parkeri and R. amblyommii.  Eleven 
patients had seroconversions against a single antigen, one against R. rickettsii, four against 
R. parkeri, and six against R. amblyommii.  Three patients had seroconversions against both 
R. parkeri and R. amblyommii antigens.  
 
 
 
Figure 8. Proportional Venn diagram showing seroconversions to R. rickettsii, R. parkeri, 
and R. amblyommii antigens and degree of cross-reactivity by indirect immunofluorescent 
assay (generated by http://venndiagram.tk/). 
 
The ability to detect seroconversions to R. parkeri and R. amblyommii using R. rickettsii 
antigen was poor, as measured by positive percent agreement of 50% and 43.8%, 
respectively (Table 9).  The majority of positive agreement between seroconversion 
Antigen Number of  
seroconversions 
R. rickettsii only 1 
R. parkeri only 4 
R. amblyommii only 6 
R. rickettsii and             
R. parkeri 
0 
R. rickettsii and                
R. amblyommii  
0 
R. parkeri and                  
R. amblyommii 
3 
R. rickettsii, R. 
parkeri,  and  R. 
amblyommii 
7 
R. rickettsii 
 
R. parkeri 
R. amblyommii 
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classifications was due to broad cross-reactivity to all three antigens.  The negative percent 
agreement with R. rickettsii antigen was equally high for both R. parkeri and R. amblyommii 
antigens (98.9%).  There was very strong agreement between the seroconversion 
classification of the original test and the retesting with R. rickettsii antigen (100% positive 
percent agreement and 98% negative percent agreement).  
 
Comparison Positive Percent 
Agreement 
Negative Percent 
Agreement 
R. rickettsii and 
R. parkeri 
50.0% 98.9% 
R. rickettsii and 
R. amblyommii 
43.8% 98.9% 
R..rickettsii 
(retest) and  
R. rickettsii 
(original test) 
100% 98.0% 
 
Table 9. Assessment of seroconversion classification agreement between R. rickettsii, R. 
parkeri, and R. amblyommii antigens. 
 
Clinical characteristics of seroconverters  
Surveillance reports were available for half of the patients (n=53).  Of these, 12 reports 
were available from patients who seroconverted to at least one of the SFGR antigens.  
Fever, thrombocytopenia, leukopenia, elevated liver enzymes, and acute renal failure 
occurred more frequently among seroconverters, while skin rash was more common among 
patients who did not seroconvert (Table 8).  Headache and myalgias occurred with similar 
frequency in both groups.   Hospitalization was more common in seroconverters, however 
no deaths were reported among any of the patients included in this study.   
Similar frequencies of signs and symptoms was observed between patients who 
seroconverted to all three antigens compared to those who seroconverted to R. parkeri 
and/or R. amblyommii, with the exception of skin rash (Table 10).  None of the patients who 
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seroconverted exclusively to R. parkeri and/or R. amblyommii antigens reported a rash, as 
compared to three of five patients with seroconversions to all three antigens.  Hospitalization 
occurred in two seroconverters; in a patent who seroconverted to R. parkeri (patient 70) and 
in another patient who seroconverted to R. amblyommii (patient 31, who also seroconverted 
to Ehrlichia chaffeensis in the original testing).  Both patients suffered from multiple 
symptoms suggestive of infection with a viral or rickettsial agent.   
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1
Nausea, diarrhea, weakness, cough, sweats. 
2
Elevated liver enzymes, thrombocytopenia, leukopenia, and anemia. 
3
In the original testing this 
patient     seroconverted to R. rickettsii and E. chaffeensis. 
4
Elevated liver enzymes, acute renal failure, thrombocytopenia, leukopenia, and anemia.  
Table 10.  Clinical characteristics for patients with surveillance reports available who seroconverted to R. rickettsii, R. 
parkeri, and/or R. amblyommii antigens (n=12).  Seroconversions are highlighted in bold. 
 IFA Titers (acute, convalescent) Symptoms Prescrib
ed Abx 
Hospit
alized 
Discharge 
diagnosis Pt 
No. 
R. 
rickettsii 
R. 
parkeri 
R. 
amblyommii 
Fever Rash H/a Myalgia Other 
3 <1:64, 
1:256 
<1:64, 
1:1024 
<1:64,  
1:512 
+ + - - - + - Presumed 
RMSF 
42 1:128, 
1:1024 
1:512, 
>1:2048 
1:128,  
>1:2048 
+ - - + Leukopenia na - na 
56 <1:64, 
1:512 
<1:64, 
≥1:2048 
<1:64,  
≥1:2048 
+ + + + Lethargy, 
thrombocytopenia 
+ - RMSF 
58 <1:64, 
1:1024 
<1:64, 
1:512 
1:64,  
1:512 
+ - + + Nausea, vomiting +  Febrile 
illness, 
possible 
RMSF 
68 <1:64, 
1:2048 
<1:64, 
≥1:2048 
<1:64,  
1:2048 
- + - - Cough + - Rash, 
unspecified 
88 1:512, 
1:256 
1:1024, 
1:256 
1:1024, 
1:256 
+ - + + Multiple
1
 + - na 
109 1:256, 
1:128 
1:256, 
1:1024 
1:256,    
1:1024 
+ - na na na na - na 
70 1:256, 
1:256 
1:256, 
1:1024 
1:256,  
1:256 
+ - + + Multiple
2
 + + na 
93 1:512, 
1:512 
1:2048, 
1:512 
1:1024,  
1:1024 
- - - - - + - na 
31 1:128, 
1:256
3
 
1:256, 
1:256 
1:256, 
1:1024 
+ - - - Multiple
4 
+ + Tick-borne 
illness 
44 1:128, 
1:256 
1:512, 
1:1024 
1:64,  
1:512 
na na na na na na - na  
76 1:512, 
1:256 
1:1024, 
1:2048 
1:512,  
1:2048 
- - - + Fatigue + - na 
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D. Discussion 
This is the first study to evaluate reactivity of paired sera from suspected RMSF patients 
against R. rickettsii, R. parkeri, and R. amblyommii antigens concurrently.  These antigens 
are likely to represent the species of SFGR that occur in tick vectors most frequently in 
North Carolina based on current knowledge.  Although the seroconversions observed 
cannot be used to infer etiology due to cross-reactivity, the greater number of unique 
seroconversions to R. parkeri and R. amblyommii than to R. rickettsii indicate that species of 
SFGR other than R. rickettsii may be causing infections among North Carolina residents.  
These results also suggest that serologic testing of paired samples using R. rickettsii 
antigen may result in missed cases of spotted fever rickettsioses caused by other species of 
SFGR, and the specificity of R. rickettsii antigen for RMSF may be better than expected.  
Thus, even the current “gold standard” for serologic diagnosis of SFGR has significant 
limitations. 
The large relative frequency of seroconversions to R. amblyommii was not unexpected 
in the context of previous work by Apperson et al [15].  Active surveillance for tick-borne 
diseases in a central North Carolina county resulted in the identification of several patients 
with mild illness in which initial testing failed to confirm RMSF.  Upon further testing with 
both R. rickettsii and R. amblyommii antigens three patients seroconverted against R. 
amblyommii in that study.  At this time, R. amblyommii has not been recognized as a human 
pathogen, but the high prevalence in lone star ticks creates ample opportunity for exposure 
and potential infection of human hosts [21, 23, 43].  Seroconversions to R. amblyommii 
among ill patients described in this report provides further evidence that infections and 
illness caused by R. amblyommii may be occurring.  We also anticipated that we would 
detect seroconversions to R. parkeri, a known human pathogen that was found in 29% of 
gulf coast ticks (Amblyomma maculatum) in a recent entomologic survey in North Carolina 
[40].   
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It is well known that there is serologic cross-reactivity between species of SFGR, and as 
a result, serologic tests cannot be used to infer etiology [119].  Serologic cross-reactivity 
between R. rickettsii and R. parkeri antigens has been described previously for patients with 
single IFA titers.  Raoult and Paddock retested sera from 15 patients diagnosed with RMSF 
using class-specific IFA with R. rickettsii and R. parkeri antigens [59].  Equal titers were 
observed for six patients, while 4 patients had higher titers to R. rickettsii and 5 patients had 
higher titers to R. parkeri.  Western blot analysis of 4 patients with higher titers against R. 
parkeri provided additional evidence of infection with R. parkeri.  Paddock et al conducted 
comparative class specific IFA from 6 confirmed and 6 probable cases of R. parkeri 
rickettsiosis using R. parkeri, R. rickettsii, R. amblyommii, and R. akari antigens [36].  IgG 
geometric mean titers were higher against R. rickettsii than for any other antigen.  These 
studies illustrate that comparison of single titers is unreliable for distinguishing cases of 
RMSF and R. parkeri rickettsiosis.  By evaluating reactivity of acute and convalescent paired 
sera, we found that some patients showed rising or falling titers to multiple rickettsiae which 
is consistent with the cross-reactivity observed in previous studies.  It is also possible, but 
highly unlikely that patients could have been co-infected with multiple species of rickettsiae.  
Notably, we found that some patients seroconverted to only a single antigen, indicating that 
extensive cross-reactivity between SFGR antigens may not be present in all cases. 
Limitations of this study include the lack of clinical data for all patients and the variability 
in the level of completeness of those for which data are available.  The small number of 
patients with surveillance reports available prevents us from making conclusions on the 
association between seroconversion to specific antigens and clinical signs and symptoms.  
Due to the eligibility requirement of having paired sera, the patients in this study are likely to 
have suffered from more severe illnesses, which led the medical provider to order repeated 
testing for tick-borne pathogens.  By limiting our study to these patients, it is possible that 
we excluded many cases of mild disease caused by SFGR.  Curiously, there were some 
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patients with paired sera who had no reported signs or symptoms.  In a few surveillance 
reports, it was noted that testing was done as a precaution after multiple tick bites, although 
none of those patients seroconverted in this study.   
It is clear that while R. rickettsii is still circulating and causing disease among people 
living in the southern and southeastern US, residents are also being exposed to and 
infected by other SFGR carried by ticks in these regions.  Some of these SFGR, such as R. 
parkeri, have been shown to cause human disease, while the pathogenic potential of others 
such as R. amblyommii, R. montanensis, and R. rhipicephali has yet to be determined.  Until 
more specific serologic diagnostic methods are developed which can distinguish between 
species of SFGR, or the use of molecular detection techniques becomes routine, the relative 
contributions of different species of SFGR to human morbidity will remain unclear.  Active 
surveillance for mild cases of suspected tick-borne illness, which include paired serology 
and molecular detection, are needed to determine the etiologies of SFGR infections in this 
region.  If current serological methods continue to be the standard for diagnosis and 
surveillance of spotted fever group rickettsioses, inclusion of antigens for all species known 
to cause human disease in the relevant geographic region should be considered to prevent 
missed infections.   
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Chapter 6 
EFFECTIVENESS OF LONG-LASTING PERMETHRIN IMPREGNATED UNIFORMS FOR 
TICK BITE PREVENTION IN FORESTRY, PARKS, AND WILDLIFE WORKERS 
 
A. Introduction 
In the US, over 34,000 cases of tick-borne illnesses including Lyme disease, spotted 
fever group rickettsioses, ehrlichiosis, and anaplasmosis were reported in 2010 [7]. The true 
incidence is likely to be higher due to under-reporting [1]. The incidence of tick-borne 
diseases is on the rise and new tick-borne pathogens are emerging.  
Tick-borne diseases are an occupational risk for outdoor workers, particularly among 
forestry workers [67]. A recent serosurvey of National Park Service employees showed that 
22% of employees were seropositive for previous exposure to spotted fever group 
rickettsiae, 3% for Ehrlichia chaffeensis, and 8% for Anaplasma phagocytophilum [120]. 
Tick bite prevention methods recommended by the National Institute for Occupational 
Safety and Health for outdoor workers, include: wearing light colored protective clothing 
(long sleeves, long pants, and hat), tucking pants into socks or boots, regular application of 
insect repellent (at least 20% DEET) to exposed skin and clothing, spraying work clothing 
with permethrin, and thoroughly checking your body for ticks daily [60]. The most commonly 
used form of permethrin for clothing treatment is a self-applied permethrin aerosol spray. 
Under controlled conditions, self-application of permethrin to clothing can provide nearly 
100% protection against questing ticks including Amblyomma americanum [96, 98, 101, 
121], Dermacentor variabilis [96, 98], Ixodes scapularis [98, 99, 121], and Ixodes pacificus 
[100]. This high rate of protection, however, is not sustained over long periods of wear or 
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after multiple washings [100, 101]. Furthermore, adherence to these recommendations, 
even among those who work in highly endemic areas for tick-borne disease, appears to be 
poor [61, 62, 87, 120]. Thus, more effective and user-friendly tick-bite prevention methods 
are needed. 
A factory-based method for long-lasting permethrin impregnation (LLPI) of textiles using 
a proprietary formulation of permethrin has been shown to retain tick-repellent activity over 
70 washes in laboratory studies [107, 122].  Clothing treated with this method is 
commercially available at many outdoor retailers, and is a key component of the Department 
of Defense Insect Repellent System [123, 124].  An open-label pilot study was conducted to 
assess the effectiveness of this LLPI clothing for the prevention of tick bites among 16 
outdoor workers from the North Carolina Division of Water Quality [110]. Subjects wearing 
LLPI clothing had 93% fewer tick bites compared to subjects using standard tick bite 
prevention measures. To evaluate this intervention in a more rigorous manner, a double 
blind randomized-controlled trial of LLPI uniforms was conducted among outdoor workers 
from North Carolina’s Divisions of Parks and Recreation, Forestry, and Wildlife. 
B. Methods 
Study design 
A double-blind randomized intervention was conducted to determine whether wearing 
long-lasting permethrin impregnated uniforms results in fewer tick bites among outdoor 
workers. The study included follow-up over two tick seasons (March through September 
2011 and 2012).  The institutional review board at the University of North Carolina at Chapel 
Hill approved the study protocol (IRB# 10-1027). All subjects completed written informed 
consent. 
Participants 
Eligible participants included employees of the North Carolina Forest Service, North 
Carolina Division of Parks and Recreation, North Carolina Wildlife Resources Commission, 
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and North Carolina County and Local Parks and Recreation who worked in the eastern or 
central North Carolina, who were over 18 years of age, who spent an average of ten or more 
hours of outdoor work per week during tick season, and who were required to wear a 
uniform while on the job. Exclusion criteria include pregnancy, non-English speakers, or 
having a known allergy to insecticides.  Informational meetings were conducted at state and 
local parks and forestry and wildlife offices throughout the study area between October 2010 
and April 2011, and eligible employees were invited to enroll.  Subjects were assigned a 
study ID number upon enrollment and given a small flashlight and six pairs of boot socks as 
a token of appreciation for their participation.  After the first year of follow-up, subjects were 
given an additional six pairs of socks as incentive to complete the final year of follow-up. 
Randomization and masking 
Prior to the start of enrollment, each ID number was assigned to either the treatment or 
control group through block randomization using block sizes of six, which were generated 
through random numbers by computer, with 1:1 allocation for the treatment or control 
interventions.  The randomization list was generated by the study statistician and none of 
the study personnel or investigators had access to this list until after data collection was 
completed.   
Intervention 
All subjects were asked to send all of their spring and summer work uniforms, including 
shirts, T-shirts, pants, shorts, hats, and socks directly to the treatment facility.  Once the 
uniforms were received, all items were labeled with the subject’s ID number and either 
treated with permethrin according to the factory-based proprietary process of long-lasting 
permethrin impregnation of clothing (treatment), or were simply washed and dried in a 
commercial washer/dryer (control). In addition, according to their treatment group, subjects 
were either given six pairs of treated or untreated boot socks at start of each tick season. 
Subjects were instructed to send any new uniforms purchased during the study period to the 
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treatment facility before wearing them. All subjects were instructed to launder their clothing 
as they normally would and to continue with their usual tick bite prevention measures 
(including use of repellents).   
Data Collection 
After completion of informed consent, participants completed a baseline questionnaire, 
which collected demographic and occupational information, history of tick-bites and tick 
exposure in the past year, history of tick-borne disease, and use of tick-bite prevention 
measures. The follow-up periods consisted of two consecutive tick seasons (2011 and 
2012), starting the week of March 15, 2011 or the week the subject started wearing their 
study uniforms and continuing through the last week of September. During the follow-up 
periods, all subjects were asked to keep a diary of all tick bites (attached ticks) which were 
recorded on weekly tick bite logs. For each entry in the log, subjects recorded the date of 
the tick bite(s), the number of tick bites, the location of the tick bites on the body, the county 
where the tick bite(s) were most likely to have been acquired, whether they were on the job 
when the tick bite(s) were acquired, whether they had been using insect repellent at the time 
of the bite(s) and the type of repellent, and whether the tick(s) were collected. Subjects also 
recorded the number of work hours and non-work hours spent outdoors each week on their 
weekly tick bite logs. Subjects were provided with a tick removal kit, including forceps and 
collection vials, and were encouraged to submit any attached ticks for identification. At the 
end of the first and second years, all subjects were asked to complete a follow-up 
questionnaire. After all data collection was completed, subjects were asked to guess 
whether they were in the treatment or control group, and provide the reason for their guess.   
Adverse events and tick-borne illnesses 
An adverse event was defined as any report of adverse effects that a participant 
believed to be related to their uniforms. In the case of an adverse event report, the study 
physician would be unblinded so it could be determined whether that subject was in the 
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treatment or control group.   If an adverse reaction occurred related to a subject’s treated 
uniforms, the study would pay to replace all of the participants’ uniforms. All subjects were 
also instructed to report any illnesses they believed might be related to a tick bite, including 
fever, rash, headache, muscle aches, or extreme tiredness within three weeks of a tick bite. 
In the case of an illness the subject consulted with the study physician or their own 
physician and sera were collected for testing against tick-borne antigens. 
Statistical analysis 
The analyses, conducted in 2013, followed the intent to treat principle. Baseline 
characteristics of the treatment and control groups were compared using the Pearson chi-
square test for dichotomous variables, Mantel-Haenszel chi-square test for ordinal variables, 
and Student’s t test for continuous variables. P-values less than 0.05 were considered 
statistically significant. Protective effectiveness (1 – the incidence rate ratio) [116] and 95% 
confidence intervals for comparing reported tick bites between the treatment and control 
groups were calculated using a generalized estimating equations (GEE) approach for 
Poisson regression. The use of GEE methods accounted for the within subject correlation 
due to repeated measures using a working correlation matrix. The GEE model used to 
calculate the protective effectiveness of the LLPI clothing used a Poisson distribution with a 
log link, and included terms for treatment, year of follow-up and the interaction of treatment 
and year of follow-up, with an offset variable for log outdoor work hours..  No other 
covariates were included in the model based on our evaluation of possible confounding by 
baseline variables using a 10% change in estimate criteria.  The incidence of tick bites was 
calculated as the total number of work-related tick bites per 100 hours spent working 
outdoors. Estimates were stratified by year of follow-up to examine whether the treatment 
effect waned with continued wear/washing.  Incidence rate differences and confidence 
intervals were calculated by inverse weighting of tick bites by the average outdoor work 
hours in the corresponding treatment group, so that the variance of the rate difference could 
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be estimated using normal approximation. Secondary outcomes, including chigger (larval 
stage mites in the family Trombiculidae) bites and mosquito bites, were compared using the 
Pearson chi-square test for dichotomous variables. The success of blinding was assessed 
using Bang’s blinding index, with values between -0.2 and 0.2 used as the threshold for 
successful blinding.[125]  All analyses were performed using SAS (version 9.2, SAS Institute 
Inc., Cary, NC, USA) or Stata (Release 12, StataCorp LP, College Station, TX). 
C. Results 
Study population 
Over two years of recruitment 159 subjects were enrolled and randomized. Twenty-six 
(16%) subjects never sent in their uniforms and were excluded (Figure 9). At baseline there 
were no significant differences in demographic and other characteristics between the 
treatment and control group (Table 11). The majority of subjects were white males, with a 
college degree and had been working in their current position for an average of 8 years. The 
number of tick bites reported in the year prior to enrollment as reported on the baseline 
questionnaire was similar for both groups. Twenty-six subjects dropped out or were lost to 
follow-up after the first year, including three subjects that did not submit any tick bite logs. 
Drop out was primarily due to subjects who moved or were transferred to jobs outside the 
study area (n=12). Subjects who were lost to follow-up or dropped out of the study did not 
differ from those who remained in the study according to treatment status, demographic 
characteristics, and outcome (mean tick bites per week), so we felt that the missing 
completely at random assumption was reasonable and hence missing data due to dropout 
were treated as noninformative and ignorable (Table 12).  
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Figure 9.  Randomization and follow-up of study participants. aSix subjects which were enrolled after the first tick season were only 
followed for one year.  Two subjects did not submit any ticks logs during year 1 but began submitting logs in year 2.  Three subjects 
did not submit any tick logs. 
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Treatment group 
(n=67) 
Control group 
(n=66) 
Sex – no. (%)   
  Male 52/66 (78.8) 55/66 (83.3) 
  Female 14/66 (21.2) 11/66 (16.7) 
Age – mean±SD 39.1 ± 9.2 38.8 ± 9.3 
Race – no. (%)   
  White 56/58 (96.6) 58/59 (98.3) 
  Black 2/58 (3.4) 0/59 (0.0) 
  Other 0/58 (0.0) 1/59 (1.7) 
Education – no. (%)   
  High school or less 5/65 (7.7) 10/66 (15.2) 
  Some college 20/65 (30.8) 14/66 (21.2) 
  Bachelor or graduate degree 40/65 (61.5) 42/66 (63.6) 
Work Division – no. (%)   
  NC Forest Service 21/66 (31.8) 27/66 (40.9) 
  NC Division of Parks and Recreation 31/66 (47.0) 25/66 (37.9) 
  NC Wildlife Resources Commission 9/66 (13.6) 10/66 (15.2) 
  NC Local or County Parks and Recreation 5/66 (7.6) 4/66 (6.1) 
Years in current position – mean±SD 7.9 ± 6.7 8.2 ± 6.8 
Number of tick bites in previous year – mean±SD 19.3 ± 32.0 19.6 ± 39.3 
Previous diagnosis with a tick-borne illness
c
 – no. (%)   
  Lyme disease 4/67 (6.0) 4/66 (6.1) 
  Rocky Mountain spotted fever 6/67 (9.0) 7/66 (10.6) 
  Ehrlichiosis 2/67 (3.0) 3/66 (4.6) 
  Anaplasmosis 0/67 (0.0) 0/66 (0.0) 
  Babesiosis 0/67 (0.0) 0/66 (0.0) 
Use of tick bite prevention measures
d
 – no. (%)   
  Long pants 62/66 (93.9) 62/65 (95.4) 
  Long sleeves 48/57 (84.2) 52/59 (88.1) 
  Hat 43/63 (68.2) 38/64 (59.4) 
  Tucked or taped pant legs 5/60 (8.3) 7/59 (11.9) 
  Repellent on skin 22/64 (34.4) 22/61 (36.1) 
  Repellent on clothing 38/65 (58.5) 35/65 (53.8) 
  Tick checks after working outdoors 58/66 (87.9) 60/65 (92.3) 
Use of self-applied permethrin on clothing – no. (%) 30/67 (44.8) 34/66 (51.5) 
Number of uniforms submitted – mean±SD   
     Shirts 15.4 ± 10.6 13.9 ± 9.9 
     Pants 9.1 ± 5.1 9.2 ± 6.5 
     Socks 8.4 ± 6.0 8.5 ± 6.7 
     Hats 1.7 ± 2.0 1.3 ± 1.5 
 
Table 11.  Demographic characteristics and history of tick bites, tick-borne illness and usage 
of preventive measures by treatment group. aBased on self-report. bReported using these 
measures at least 50% of the time while working outdoors. 
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Active subjects 
(n=107) 
Lost to follow-up 
(n=26)
a
 
Did not send 
uniform 
(n=26)
b
 
Assigned intervention    
  Treatment 56/107 (52.3) 11/26 (42.3) 12/26 (46.2) 
  Control 51/104 (47.7) 15/26 (57.7) 14/26 (53.8) 
Mean bites/week of follow-up - 
mean±SD 
0.187±0.337 0.229±0.533 n/a 
Sex – no. (%)    
  Male 87/106 (82.1) 20/26 (76.9) 18/20 (90.0) 
  Female 19/106 (17.9) 6/26 (23.1) 2/20 (10.0) 
Age – mean±SD 39.7 ± 9.4 35.7 ± 8.0 45.7 ± 12.2* 
Race – no. (%)    
  White 94/97 (96.9) 13/13 (100.0) n/a 
  Black 2/97 (2.1) 0 n/a 
  Other 1/97 (1.0) 0 n/a 
Education – no. (%)    
  High school or less 11/105 (10.5) 4/26 (15.4) 3/18 (16.7) 
  Some college 27/105 (25.7) 7/26 (26.9) 7/18 (38.9) 
  Bachelor or graduate degree 67/105 (63.8) 15/26 (57.7) 8/18 (44.4) 
Work Division – no. (%)    
  NC Forest Service 43/106 (40.6) 5/26 (19.2) 7/20 (35.0) 
  NC Division of Parks and Recreation 42/106 (39.6) 14/26 (53.8) 10/20 (50.0) 
  NC Wildlife Resources Commission 14/106 (13.2) 5/26 (19.2) 0/20 (0) 
  NC Local or County Parks and 
Recreation 
7/106 (6.6) 2/26 (7.7) 3/20 (15.0) 
Years in current position – mean±SD 8.3 ± 7.1 6.9 ± 5.3 6.0 ± 4.8 
Number of tick bites in previous year 
– mean±SD 
18.9 ± 27.6 21.4 ± 58.1 8.1 ± 12.7** 
Use of tick bite prevention measures
c
 
– no. (%) 
   
  Long pants 99/105 (94.3) 25/26 (96.2) 13/18 (72.2)** 
  Long sleeves 14/94 (14.9) 2/22 (9.1) 4/15 (26.7) 
  Hat 64/103 (62.1) 17/24 (70.8) 13/18 (72.2) 
  Tucked or taped pant legs 12/97 (12.4) 0/22 (0) 3/15 (20.0) 
  Repellent on skin 33/99 (33.3) 11/26 (42.3) 10/17 (58.8)* 
  Repellent on clothing 59/105 (56.2) 14/25 (56.0) 11/19 (57.9) 
  Tick checks after working outdoors 95/105 (90.5) 23/26 (88.5) 17/20 (85.0) 
Use of self-applied permethrin on 
clothing – no. (%) 
52/106 (49.1) 12/26 (46.2) 4/20 (20.0)* 
 aSubjects lost to follow-up after the first year.  bBaseline questionnaires were available from 
20 of the 26 subjects that did not submit uniforms. cReported using these measures at least 
50% of the time while working outdoors.*p<0.05, **p<0.01, as compared to active subjects. 
 
Table 12.  Comparison of assigned intervention, mean observed outcome, and baseline 
characteristics of active subjects, those lost to follow-up after the first year and those who 
never submitted uniforms. 
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Protective effectiveness against tick bites 
The mean number of person-weeks of follow-up was similar for the treatment group and 
control group (41.1 person-weeks and 42.2 person-weeks, respectively). The number of 
work-related tick bites (bites reported as having been acquired on the job) reported by group 
and incidence of tick bites per person-week stratified by year of follow-up are shown in 
Table 13. In total, 1,045 work-related tick bites were reported over 5,251 weeks of follow-up. 
The incidence of tick bites in year one was 1.37 bites per 100 outdoor work hours in the 
control group and 0.24 bites per 100 outdoor work hours in the treatment group, with an 
incidence rate difference of -1.13 (95% CI: -1.78, -0.50).  In year two the incidences were 
1.05 and 0.69 tick bites per person-week in the control and treatment groups, respectively, 
with an incidence rate difference of -0.36 (95% CI: -1.12, 0.40).  The incidence of tick bites 
was significantly less among subjects in the treatment group during the first year of follow-
up, with a protective effectiveness of 0.82 (95% CI: 0.66, 0.91, p<0.001) against tick bites for 
subjects wearing LLPI uniforms compared to subjects using their usual tick bite prevention 
measures. During the second year of follow-up the protective effectiveness was 0.34 (95% 
CI: 0.67, 0.74, p=0.38). The overall protective effectiveness for both years of follow-up was 
0.65 (95% CI: 0.29, 0.82, p=0.004). Two outliers were observed in which a subject reported 
≥50 tick bites in a single week. These were likely to be larval ticks and it is uncertain whether 
they represented true bites (attachment). When these outliers were excluded, the protective 
effectiveness for year one was 0.78 (95% CI: 0.60, 0.88) and 0.52 (95% CI: 0.01, 0.77) for 
year two (Table 14).   
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 N Total tick 
bites/total 
outdoor 
work hours 
Tick bite 
incidence 
per 100 
outdoor 
work 
hours 
Incidence 
rate 
difference 
(95% CI) 
Protective 
effectiveness  
(95% CI)      
p-
value 
Year 1       
  Treatment 64 84/34628.0 0.24 -1.13       
(-1.78, -0.50)           
0.823 
(0.655, 0.910) 
<0.00
1 
  Control 63 493a/35750.8 1.37    
Year 2       
  Treatment 53 181b/26171.5 0.69 -0.36 
(-1.12, 0.40) 
0.341              
(-0.670, 
0.740) 
0.379 
  Control 48 287/27353.0 1.05    
Years 1 & 2       
    Treatment 66 265b/60799.5 0.44 -0.79 
(-1.34, -0.26) 
0.646      
(0.288, 0.824) 
0.004 
    Control 64 780a/63103.8 1.23    
 
Table 13.  Incidence of work related tick bites, by treatment group and year of follow-up. 
aOne subject reported 102 tick bites in one week.  bOne subject reported 50 tick bites in one 
week. 
 
 
 
 
 
 
 
 
 
 
 
Table 14.  Sensitivity analysis of incidence of work related tick bites, excluding weeks with 
≥50 tick bites reported by a subject. 
 
 N Total tick 
bites/total 
outdoor work 
hours 
Tick bite 
incidence 
per 100 
outdoor 
work hours 
Protective 
effectiveness 
(95% CI)     
p-value 
Year 1      
  Treatment 64 84/34628 0.243 0.777    
(0.602, 0.876) 
<0.0001 
  Control 63 391/35720.8 1.09   
Year 2      
  Treatment 53 131/26151.5 0.501 0.523   
(0.010, 0.770) 
0.047 
  Control 48 287/27353 1.05   
Years 1 & 2      
  Treatment 66 215/60779.5 0.354 0.670   
(0.423, 0.811) 
<0.0001 
  Control 64 678/63073.8 1.07   
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Secondary outcomes 
In support of the tick bite log data, 867 ticks were collected and submitted by subjects 
over both years, more from subjects in the control group (581 ticks) than from subjects in the 
treatment group (286 ticks). More than 90% of the submitted ticks were lone star ticks (A. 
americanum).  Nearly all subjects reported having chigger bites and mosquito bites in the 
year prior to enrollment, with no significant differences between those assigned to the 
treatment or control groups. During both years of follow-up, the risk of having any chigger 
bites was significantly reduced among subjects in the treatment group (year one RR=0.66, 
p<0.001 and year two RR=0.71, p=0.002) (Table 15). Almost all subjects continued to report 
having been bitten by mosquitoes during follow-up, although the proportion who reported 
having frequent mosquito bites was less among those in the treatment group (RR=0.66, 
p=0.08 in year one and RR=0.56, p=0.08 in year two) (Table 16).   
 
 
 
 
 
Table 15.  Proportion of subjects reporting any chigger bites by treatment group and year of 
follow-up. 
 
 
 
 
 
Table 16.  Proportion of subjects reporting frequent mosquito bites by treatment group and 
year of follow-up. 
 
 
Year Treatment 
group  
Control 
group  
Risk Ratio     
(95% CI) 
p-value 
Baseline 65/66 (98.5) 65/66 (98.5) 1.00 (0.96, 1.04) 1.0 
Year 1 32/57 (56.1) 50/59 (84.8) 0.66 (0.51, 0.85) <0.001 
Year 2 32/50 (64.0) 45/50 (90.0) 0.71 (0.57, 0.89) 0.002 
Year Treatment 
group  
Control 
group  
Risk Ratio     
(95% CI) 
p-value 
Baseline 43/66 (65.2) 47/66 (71.2) 0.91 (0.72, 1.16) 0.46 
Year 1 18/57 (31.6) 28/59 (47.5) 0.66 (0.42, 1.06) 0.08 
Year 2 10/50 (20.0) 18/50 (36.0) 0.56 (0.28, 1.08) 0.08 
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Blinding 
At the end of the study, all subjects were asked to guess their treatment status. Of the 
97 subjects who responded, 41/51 (80.4%) of subjects in the treatment group and 27/46 
(58.7%) in the control group guessed correctly (Table 17). Most subjects related their guess 
to the frequency of tick and chigger bites they experienced and the behavior of ticks on their 
uniforms.  Bang’s blinding index, which can be interpreted as the proportion of unblinding in 
each group, was 0.74 for the treatment group and 0.28 for the control group, indicating 
unblinding was high for both groups, although less so for the control group. 
 
Guess Blinding 
Index Treatment Control Don’t Know 
Assignment     
  Treatment (n=51) 41 3 7 0.745 
  Control (n=46) 14 27 5 0.283 
 
Table 17.   Subjects’ guesses of treatment assignment and Bang’s blinding index by group. 
 
Adverse events and tick-borne illnesses 
There were no adverse events reported that were related to the subjects’ uniforms. Five 
subjects reported illnesses suspected to be tick-related, two were confirmed (one case of 
ehrlichiosis and one case of spotted fever rickettsiosis), both among subjects in the control 
group. The other reported illnesses were a local reaction to a tick bite, viral mononucleosis, 
and a mild viral illness.  
D. Discussion 
Prevention of tick bites is critically important among outdoor workers and others with 
extensive exposure to ticks. This study demonstrated that in the first year of wear, LLPI 
uniforms significantly reduced tick bites by greater than 80% among outdoor workers even 
when usual tick bite prevention measures were employed by both groups.  The 
effectiveness of the LLPI uniforms declined in year two.  Based on laboratory knockdown 
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studies of mosquito and tick species after exposure to treated fabric, the repellency of the 
LLPI clothing used in this study is registered by the US Environmental Protection Agency to 
last through 70 launderings.  The estimated numbers of launderings of the subjects’ 
uniforms in this study, based on questionnaire data, were generally below 70-washes after 
the first year (Table 18).  Therefore, we believe that environmental conditions in the field 
(not present in laboratory studies) may also play a role in loss of effectiveness.  Subjects 
spent many outdoor hours in their uniforms; this continued exposure to various 
environmental conditions (sunlight, rain, heat) and heavy wear of uniforms may have 
contributed to the observed loss of effectiveness.  Future studies should focus on the effects 
of environmental factors on loss of permethrin and knockdown capacity of LLPI clothing. 
 Treatment 
group  
Control 
group 
Number of uniforms submitted – mean±SD   
  Shirts 15.4±10.6 13.9±9.9 
  Pants 9.1±5.1 9.2±6.5 
  Socks 8.4±6.0 8.5±6.7 
  Hats 1.7±2.0 1.3±1.5 
Frequency of washing (no. wears before washing)  – 
mean±SD 
  
  Shirts 1.34±0.60 1.30±0.52 
  Pants 1.66±0.90 1.72±0.84 
  Socks 1.01±0.12 1.08±0.28 
Estimated number of washes per yeara – mean±SD   
  Shirts 44.3±33.6 44.2±28.0 
  Pants 28.6±21.7 28.6±31.5 
  Socks 20.1±8.7 19.6±8.8 
 
Table 18.  Number of uniforms submitted, frequency of washing, and estimated number of 
washes per year, by group. aEstimated number of washes calculated assuming that subjects 
only wore the uniforms submitted for “treatment” and that they were worn 50 weeks of the 
year (assuming 2 weeks vacation). 
 
Adherence to the assigned treatment (wearing only “study” uniforms), was likely to be 
highest in first year of follow-up. The workers in this study typically purchase a number of 
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new uniforms every year and we asked that any new uniforms purchased during the study 
be sent for “treatment” before being worn. Approximately half of the subjects in each group 
submitted additional uniforms after the first year; therefore it is likely that some subjects 
wore “non-study” uniforms during the second year, which could bias the treatment effect 
toward the null.  Permethrin-treated socks have been shown to be particularly effective in 
preventing tick bites [109], as questing ticks will often encounter socks and footwear first 
after finding a human host.  Subjects were only provided with six pairs of treated (or sham-
treated) socks at the start of each year, and while most subjects submitted additional socks 
of their own at the start of the study, only 12 subjects submitted additional socks in the 
second year. Since socks tend to wear out more quickly than other pieces of clothing, it is 
unlikely that all subjects wore “study” socks exclusively. Failure to wear permethrin-treated 
socks could also have contributed to the loss of measured effectiveness in year two. 
The high degree of unblinding among subjects is a potential source of bias. However, 
there were no significant differences observed in the proportion of subjects in each group 
performing regular tick checks and using other tick bite prevention measures during follow-
up. The control group tended to use self-applied repellents more frequently, which could 
have led to an underestimation of protective effectiveness of the LLPI uniforms (Table 19).   
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Table 19.  Proportion of subjects who reported using tick bite prevention measures at least 
50% of the time during spring and summer, by year of follow-up and group. 
 
While there is potential for bias due to exclusion of subjects who did not submit uniforms, 
the proportions excluded from those assigned to the treatment and control group were 
similar. Subjects who were excluded tended to be older and had significantly fewer tick bites 
in the year prior to enrollment (Table 12). Excluded subjects also were less likely to wear 
long pants, use repellent on their skin, and use self-applied permethrin on their clothing.  We 
Tick bite prevention measure Treatment 
group  
Control group  p-value 
Long pants    
  Baseline 62/66 (94.9%) 62/65 (95.4%) 0.71 
  Year 1 54/57 (94.7%) 56/59 (94.9%) 0.97 
  Year 2 47/49 (95.9%) 45/50 (90.0%) 0.25 
Long sleeves    
  Baseline 9/57 (15.8%) 7/59 (11.9%) 0.54 
  Year 1 6/53 (11.3%) 5/56 (8.9%) 0.68 
  Year 2 5/46 (10.9%) 4/48 (8.3%) 0.68 
Hat    
  Baseline 43/63 (68.2%) 38/64 (59.4%) 0.30 
  Year 1 32/53 (60.4%) 33/58 (56.9%) 0.71 
  Year 2 30/45 (66.7%) 23/47 (48.9%) 0.09 
Tuck pant legs/tape pants to boots    
  Baseline 5/60 (8.3%) 7/59 (11.9%) 0.52 
  Year 1 3/54 (5.6%) 3/56 (5.4%) 0.96 
  Year 2 1/44 (2.3%) 3/47 (6.4%) 0.34 
Repellent on skin    
  Baseline 22/64 (34.4%) 22/61 (36.1%) 0.84 
  Year 1 9/55 (16.4%) 15/56 (26.8%) 0.18 
  Year 2 6/48 (12.5%) 11/48 (22.9%) 0.18 
Repellent on clothing    
  Baseline 38/65 (58.5%) 35/65 (53.8%) 0.60 
  Year 1 15/56 (26.8%) 23/57 (40.4%) 0.13 
  Year 2 11/46 (23.9%) 22/50 (44.0%) 0.04 
Tick check after working outdoors    
  Baseline 58/66 (87.9%) 60/65 (92.3%) 0.40 
  Year 1 52/57 (91.2%) 55/57 (96.5%) 0.24 
  Year 2 47/50 (94.0%) 43/50 (86.0%) 0.18 
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speculate that these subjects may have chosen not to send in their uniforms due to low 
perceived risk of tick bites and reluctance to use repellents. Given the evidence that those 
who opted to participate had more frequent exposure to ticks, our estimates of protective 
effectiveness are most relevant for those at high risk of tick bites.   
The vast majority of the ticks collected by subjects were lone star ticks (A. americanum), 
the most common human-biting tick in North Carolina.  Clothing that has been freshly 
treated with permethrin provides high rates of protection against several species of ticks, 
including I. scapularis, I. pacificus, I. ricinus, D. variabilis, and A. americanum [96-101, 109, 
121, 126]. Thus, LLPI clothing is likely to be protective against different tick species but 
additional long-term studies are needed in other locations. 
This study is the first randomized-controlled trial to evaluate the effectiveness of LLPI 
clothing with follow-up of subjects over an extended period of time. Efficacy of permethrin 
impregnated clothing against ticks has been demonstrated in the laboratory and in short-
duration field trials [96-101, 105, 108, 109, 121, 126]. However, traditional self-applied spray 
and dipping methods lose effectiveness unless reapplied every three to five washes [100, 
101, 104]. In an open-label pilot study, subjects wearing LLPI clothing had 93% fewer 
(p<0.0001) tick bites compared to subjects using standard tick bite prevention measures 
over one tick season [110]. The current study was designed to provide a more accurate and 
precise estimate over a longer duration of follow-up. The results of this study demonstrate 
that among high-risk individuals, LLPI uniforms are highly effective for at least one year 
against tick bites compared to existing tick bite prevention measures. Based on these 
findings, we recommend that wearing LLPI uniforms or clothing should be included as a 
standard tick bite prevention measure in addition to other recommended prevention 
measures for outdoor workers with substantial exposure to ticks, with retreatment or 
replacement of garments after one year if they are worn on a regular basis. 
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Chapter 7 
SUMMARY 
A. Seroepidemiology of spotted fever group rickettsiae in North Carolina 
1. Summary of findings 
An increasing number of entomologic and epidemiologic studies suggest that SFGR 
other than R. rickettsii are responsible for cases of spotted fever rickettsioses in the US, 
sparking a change in the surveillance case classification from “Rocky Mountain spotted 
fever” to “Spotted Fever Group Rickettsiosis (including Rocky Mountain spotted fever)”.  We 
conducted a retrospective seroepidemiologic study on paired sera that had been submitted 
for testing for tick-borne illnesses to the North Carolina State Laboratory of Public Health 
and evaluated the serologic reactivity to R. rickettsii, R. parkeri and R. amblyommii antigens. 
While cross-reactivity between antigens was observed in 10 of the 21 seroconverters, we 
found a greater number of unique seroconversions to R. parkeri and R. amblyommii than to 
R. rickettsii, which suggests that species of SFGR other than R. rickettsii may be causing 
infections among North Carolina residents.  Among the patients in this study, our ability to 
detect seroconversions to R. parkeri and R. amblyommii using R. rickettsii antigen was poor, 
indicating that using R. rickettsii antigen for serologic diagnosis may result in missed cases 
of spotted fever rickettsioses caused by other species of SFGR. 
2. Findings in context of current literature 
This is the first study to evaluate reactivity of paired sera from suspected RMSF patients 
against R. rickettsii, R. parkeri, and R. amblyommii antigens concurrently.  Our discovery of
patients who seroconverted to R. amblyommii but not R. rickettsii is consistent with a 
previous study of patients presenting to primary care physicians in central North Carolina
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with symptoms suggestive of a tick-borne illness [15].  Serologic cross-reactivity to R. 
rickettsii and R. parkeri antigens among patients with probable or confirmed SFGR 
infections has been described previously [36, 59]. While cross-reactivity was also observed 
in our study, the use of more stringent criteria (seroconversion vs. comparison of single 
titers) allowed us to distinguish between seropositivity due to previous exposure and a 
probable recent infection.  
3. Public health implications 
This study highlights the limitations of the R. rickettsii IFA (the current gold standard), for 
serologic diagnosis of spotted fever rickettsioses in the US. Unless more specific serologic 
diagnostic methods are developed which can distinguish between species of SFGR or the 
use of molecular detection techniques becomes routine, the relative contributions of different 
species of SFGR to human morbidity will remain unclear.  For the time being, it is likely that 
the IFA will continue to be the standard for diagnosis and surveillance for spotted fever 
group rickettsioses, and based on the results of this study I recommend that R. parkeri 
antigen should be considered for inclusion in addition to R. rickettsii to prevent missed 
cases. 
4. Future research 
Prospective studies of patients with suspected tick-borne illness are needed to better 
describe the etiologies of SFGR infections in this region. These studies should include 
paired serologies as well as attempts at molecular detection of rickettsia from blood, serum, 
and skin biopsies (and tick specimens if available).  Improved real-time PCR assays with 
lower limits of detection may provide the increased sensitivity needed for these types of 
studies [117, 127]. 
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B. Preventing tick bites among outdoor workers using permethrin impregnated uniforms  
1. Summary of findings 
Prevention of tick bites is critically important among outdoor workers and others with 
extensive exposure to ticks, as it is currently the only way to avoid infection with tick-borne 
pathogens in the US.  This study demonstrated that in the first year of wear, effectiveness of 
long-lasting permethrin impregnated uniforms for the prevention of work-related tick bites 
was 0.82 (95% CI: 0.66, 0.91) and 0.34 (95% CI: -0.67, 0.74) for the second year of wear.  
LLPI uniforms significantly reduced tick bites among outdoor workers even when usual tick 
bite prevention measures were employed by both groups.  The effectiveness of the LLPI 
uniforms declined during the second year of follow-up, which is likely due to wash/wear out 
of the permethrin or non-adherence.  For recreational users of LLPI clothing, the persistence 
of high levels of protection against ticks is likely to be much longer than observed in this 
study. 
2. Findings in context of current literature 
Nearly all previous studies which have evaluated the efficacy of permethrin treated 
clothing against ticks were based on field trials with a limited number of subjects walking 
through tick infested areas for a short time period, usually several hours.  The efficacy of 
permethrin impregnated clothing against ticks has been demonstrated to be near 100% in 
many laboratory studies and short duration field trials [96-101, 105, 108, 109, 126].  Efficacy 
estimates from these field trials are based on the total number of ticks found on the subjects 
wearing treated or untreated garments.  While these field studies provide valuable 
information on the performance of permethrin treated clothing under controlled conditions, 
the results of these studies cannot be used to infer the effectiveness of the treated clothing 
against tick bites under actual field conditions and usage, and over an extended period of 
time.  In reality, users of permethrin treated clothing are exposed to various types of outdoor 
environments and weather conditions, and have varying levels of usage of other tick bite 
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prevention measures, all which can affect the probability of being bitten by a tick. Traditional 
self-applied spray and dipping methods require regular reapplication every 3-5 washes to 
maintain high levels of activity after laundering [100, 101, 104].  With the availability of 
improved formulations and methods for impregnating fabrics with long-lasting permethrin, 
studies investigating the longevity, effectiveness, and safety of LLPI clothing under regular 
wearing and washing conditions are warranted.   In a pilot study, we found that subjects 
wearing LLPI clothing had a 93% reduction (p<0.0001) in the total incidence of tick bites 
compared to subjects using standard tick bite prevention measures over one tick season 
[110]. The larger randomized study was designed to provide a more accurate and precise 
estimate over a longer duration of follow-up.  Our findings indicate that among high risk 
outdoor workers, LLPI uniforms are highly effective for at least one year against tick bites 
compared to existing tick bite prevention measures.   
3. Public health implications 
Based on our findings we recommend that wearing LLPI garments (including pants, 
shirts, socks, and hats) should be included as a standard tick bite prevention measure in 
addition to other recommended prevention measures for outdoor workers with substantial 
exposure to ticks.  Wearing LLPI uniforms could be a practical solution for tick bite and tick-
borne disease prevention because it is simple, safe, effective, and requires no additional 
effort other than getting dressed. It will appeal to employers who are concerned about the 
risk of tick bites and tick-borne diseases among their employees, and also as a cost-saving 
strategy in an effort to reduce lost time and medical claims due to tick-related illnesses. 
Efforts are currently being made to inform policymakers from NCDENR and other divisions 
about the results of the study, and to discuss options for making treated uniforms available 
to employees. 
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4. Future research 
Since this is the first study of its kind, additional studies are needed in other study 
populations to evaluate the effectiveness against other species of ticks or disease vectors.  
Of particular value would be studies to demonstrate efficacy against Ixodes scapularis, the 
tick vector for Lyme disease, babesiosis and anaplasmosis.  Future studies should also 
examine whether treatment of full uniforms is needed to achieve high levels of protection, or 
whether partial treatment of uniforms (such as pants and socks only) can provide good 
protection.  In addition, the cost-effectiveness of treating whole or partial uniforms for tick 
bite prevention needs to be assessed to assist policymakers in decisions on providing 
treated uniforms to employees.  Future studies should also incorporate testing to quantify 
the concentration of permethrin and knock-down activity in “worn out” treated uniforms. 
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APPENDIX A: RMSF CASE REPORT FORM 
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APPENDIX B: TICS BASELINE QUESTIONNAIRE 
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APPENDIX C: TICS WEEKLY TICK BITE LOG 
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